<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName A++V2.4.dtd?>
  <?SourceDTD.Version 2.4?>
  <?ConverterInfo.XSLTName springer2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Genet Genomics</journal-id>
      <journal-title-group>
        <journal-title>Molecular Genetics and Genomics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1617-4615</issn>
      <issn pub-type="epub">1617-4623</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3064890</article-id>
      <article-id pub-id-type="pmid">21409565</article-id>
      <article-id pub-id-type="publisher-id">612</article-id>
      <article-id pub-id-type="doi">10.1007/s00438-011-0612-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>EMSY</italic> overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cousineau</surname>
            <given-names>Isabelle</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Belmaaza</surname>
            <given-names>Abdellah</given-names>
          </name>
          <address>
            <phone>+1-514-8908000</phone>
            <fax>+1-514-4127591</fax>
            <email>abdellah.belmaaza@umontreal.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Microbiology and Immunology, Faculty of Medicine, Universit&#xE9; de Montr&#xE9;al, Montr&#xE9;al, QC Canada </aff>
        <aff id="Aff2"><label>2</label>Centre de recherche, Centre hospitalier de l&#x2019;Universit&#xE9; de Montr&#xE9;al (CRCHUM), H&#xF4;pital Notre-Dame, Institut du Cancer de Montr&#xE9;al, 1560, rue Sherbrooke est, Pavillon J.A. de S&#xE8;ve, Y-5634, Montr&#xE9;al, QC H2L 4M1 Canada </aff>
      </contrib-group>
      <author-notes>
        <fn fn-type="com">
          <p>Communicated by A. Aguilera.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>16</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2011</year>
      </pub-date>
      <volume>285</volume>
      <issue>4</issue>
      <fpage>325</fpage>
      <lpage>340</lpage>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>12</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>2</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2011</copyright-statement>
      </permissions>
      <abstract id="Abs1">
        <p><italic>EMSY</italic> links the BRCA2 pathway to sporadic breast/ovarian cancer. It encodes a nuclear protein that binds to the BRCA2 N-terminal domain implicated in chromatin/transcription regulation, but when sporadically amplified/overexpressed, increased EMSY level represses BRCA2 transactivation potential and induces chromosomal instability, mimicking the activity of <italic>BRCA2</italic> mutations in the development of hereditary breast/ovarian cancer. In addition to chromatin/transcription regulation, EMSY may also play a role in the DNA-damage response, suggested by its ability to localize at chromatin sites of DNA damage/repair. This implies that <italic>EMSY</italic> overexpression may also repress BRCA2 in DNA-damage replication/checkpoint and recombination/repair, coordinated processes that also require its interacting proteins: PALB2, the partner and localizer of BRCA2; RPA, replication/checkpoint protein A; and RAD51, the inseparable recombination/repair enzyme. Here, using a well-characterized recombination/repair assay system, we demonstrate that a slight increase in EMSY level can indeed repress these two processes independently of transcriptional interference/repression. Since EMSY, RPA and PALB2 all bind to the same BRCA2 region, these findings further support a scenario wherein: (a) <italic>EMSY</italic> amplification may mimic BRCA2 deficiency, at least by overriding RPA and PALB2, crippling the BRCA2/RAD51 complex at DNA-damage and replication/transcription sites; and (b) BRCA2/RAD51 may coordinate these processes by employing at least EMSY, PALB2 and RPA. We extensively discuss the molecular details of how this can happen to ascertain its implications for a novel recombination mechanism apparently conceived as checkpoint rather than a DNA repair system for cell division, survival, death, and human diseases, including the tissue specificity of cancer predisposition, which may renew our thinking about targeted therapy and prevention.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Tumor-suppressor genes</kwd>
        <kwd>Oncogenes</kwd>
        <kwd>Development/abortion</kwd>
        <kwd>Aging</kwd>
        <kwd>Estrogens</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p><italic>EMSY</italic> amplification in sporadic breast and ovarian cancer mimics the activity of <italic>BRCA2</italic> mutations in the development of this disease&#x2019;s hereditary form (Hughes-Davies et al. <xref ref-type="bibr" rid="CR34">2003</xref>). <italic>EMSY</italic> encodes a large nuclear protein that binds to the BRCA2 N-terminal domain encoded by exon 3 of the <italic>BRCA2</italic> gene (BRCA2<sub>ex3</sub>). Adjacent to the EMSY N-terminal domain that interacts with BRCA2<sub>ex3</sub> reside conserved residues that specifically bind chromatin-remodeling HP1&#x3B2; and BS69 proteins, implicating EMSY in chromatin regulation. Whereas BRCA2<sub>ex3</sub> possesses intrinsic histone acetyltransferase (HAT) activity, chromatin-relaxation activity required for transcription, replication and recombination/repair, HP1&#x3B2; binds to methylated histones involved in chromatin assembly that usually impedes these processes. A role for EMSY in chromatin regulation is also suggested by the findings that overexpression of a truncated form of <italic>EMSY</italic> represses the transactivation potential of BRCA2<sub>ex3</sub> and induces chromosomal instability (CIN), implicating BRCA2 in the development of non-familial cancer as well (Hughes-Davies et al. <xref ref-type="bibr" rid="CR34">2003</xref>; Raouf et al. <xref ref-type="bibr" rid="CR52">2005</xref>).</p>
      <p>However, BRCA2<sub>ex3</sub> may also be directly involved in the maintenance of chromosomal stability through its interaction with RPA, single-strand DNA (ssDNA)-binding replication protein A, and PALB2, two proteins required for development of the DNA-damage response (DDR), including BRCA2/RAD51-mediated homologous recombination (HR) repair of DNA double-strand breaks (DSBs) (Wong et al. <xref ref-type="bibr" rid="CR72">2003</xref>; Xia et al. <xref ref-type="bibr" rid="CR73">2006</xref>), a well-established function of BRCA2 (Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>; Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>). Generally, DSBs, such as those generated by mega-endonucleases (i.e., I-<italic>Sce</italic>I), ionizing radiation (IR), DNA cross-linking agents or by overexpressing oncogenes, activate the DDR orchestrated by PIKKs, the serine/threonine PI3K-like kinases ATM, ATR and DNA-PK, which, once recruited/localized at sites of such lethal damage, trigger a cascade of phosphorylation events in several downstream target proteins that coordinate DNA-damage checkpoints (i.e., cell-cycle arrest) with recombination/repair or activate p53-dependent or -independent apoptosis/senescence (Shiloh <xref ref-type="bibr" rid="CR55">2003</xref>; Kastan and Bartek <xref ref-type="bibr" rid="CR38">2004</xref>; Harper and Elledge <xref ref-type="bibr" rid="CR31">2007</xref>; Branzei and Foiani <xref ref-type="bibr" rid="CR10">2008</xref>; Halazonetis et al. <xref ref-type="bibr" rid="CR30">2008</xref>).</p>
      <p>Briefly, while PALB2 links BRCA2 to BRCA1, which localizes PALB2/BRCA2/RAD51 complex at chromatin and I-<italic>Sce</italic>I/IR-induced DSBs (Xia et al. <xref ref-type="bibr" rid="CR73">2006</xref>; Zhang et al. <xref ref-type="bibr" rid="CR79">2009</xref>), RPA coats ssDNA and recruits ATR through its interacting protein ATRIP, after the localization of activated ATM and the processing of DSB ends into ssDNA by BRCA1 and MRE11/RAD50/NBS1 (MRN) complex (Kastan and Bartek <xref ref-type="bibr" rid="CR38">2004</xref>; Jazayeri et al. <xref ref-type="bibr" rid="CR37">2006</xref>). In addition, through its interaction with MRN, RPA also recruits ATR/ATRIP to ssDNA tracts at stalled forks, generated spontaneously or induced by ultraviolet (UV) light, hydroxyurea (HU) or methyl methane sulfonate (MMS) (Harper and Elledge <xref ref-type="bibr" rid="CR31">2007</xref>; Olson et al. <xref ref-type="bibr" rid="CR49">2007</xref>). MRN is the DNA-binding/bridging/unwinding/exonuclease component of BRCA1-associated genome surveillance complex (BASC) that also contains BARD1 (BRCA1-associated ring domain), ATM, ATR, the DNA-helicase BLM, and replication factors that load DNA-polymerase processivity factor proliferating cell nuclear antigen (PCNA) on the forks (Wang et al. <xref ref-type="bibr" rid="CR68">2000</xref>; Greenberg et al. <xref ref-type="bibr" rid="CR27">2006</xref>). BRCA1/MRN not only localizes ATM, ATR and BRCA2/RAD51 complexes at sites of DNA damage, but also facilitates the ability of ATR and ATM to interact with and phosphorylate several downstream targets, most notably, their proximal effector checkpoint-kinases CHK1 and CHK2, respectively, and the cohesin subunit SMC1 (structural maintenance of chromosome 1). Whereas CHK1 and CHK2 target the cyclin-dependent kinases CDK1 and CDK2 for inactivation, thereby imposing G1/S and G2/M checkpoints, SMC1 enhances sister chromatid (SC) cohesion (SCC) to keep them perfectly aligned for BRCA2/RAD51-mediated HR, thus ensuring error-free repair of DNA damage, replication-fork progression and SC segregation, thereby maintaining chromosomal stability in both structure and number (Shiloh <xref ref-type="bibr" rid="CR55">2003</xref>; Kastan and Bartek <xref ref-type="bibr" rid="CR38">2004</xref>; Branzei and Foiani <xref ref-type="bibr" rid="CR10">2008</xref>; Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>).</p>
      <p>In addition to RPA and PALB2, evidence indicates that BRCA2 may also employ EMSY in DDR development. (a) The inherited, cancer-eliciting BRCA2<sub>ex3</sub> mutations that inactivate its transactivation potential and block its binding to EMSY (Hughes-Davies et al. <xref ref-type="bibr" rid="CR34">2003</xref>) also abrogate its interaction with RPA (Wong et al. <xref ref-type="bibr" rid="CR72">2003</xref>) and PALB2 (Xia et al. <xref ref-type="bibr" rid="CR73">2006</xref>); (b) EMSY localizes to IR-induced DNA damage/repair foci (Hughes-Davies et al. <xref ref-type="bibr" rid="CR34">2003</xref>) in a manner similar to BRCA2 co-localizing with BRCA1, BARD1, MRN, RPA, RAD51 and ATR at UV-stalled forks, marked by PCNA (Scully and Livingston <xref ref-type="bibr" rid="CR53">2000</xref>); (c) EMSY-interacting HP1&#x3B2; protein binds to CAF-1, the histone chaperone chromatin-assembly factor that interacts with PCNA (Groth et al. <xref ref-type="bibr" rid="CR28">2007</xref>), and like BRCA2, CAF-1 also stabilizes replication forks; in its absence, stalled forks can collapse into DSBs (Lomonosov et al. <xref ref-type="bibr" rid="CR43">2003</xref>; Ye et al. <xref ref-type="bibr" rid="CR76">2003</xref>). CAF-1/PCNA ensures the loading of acetylated histones behind replication forks (Groth et al. <xref ref-type="bibr" rid="CR28">2007</xref>), whereas BRCA2 may use EMSY/HP1&#x3B2; to provide such histones by displacing nucleosomes ahead of such forks, allowing fork movement and RPA coating of nascent ssDNA and recruiting/activating ATR; and (d) overexpression of a truncated form of <italic>EMSY</italic> in human mammary epithelial cells induces SC-type abnormalities displayed by BRCA2-deficient cells (Raouf et al. <xref ref-type="bibr" rid="CR52">2005</xref>). Collectively, these findings raise the hypothesis that increased EMSY level may mimic BRCA2 deficiency in CIN, at least by overriding RPA and PALB2.</p>
      <p>To gain insights into this scenario, we increased EMSY level in sporadic breast cancer MCF-7 cells and determined whether it induces other phenotypes of BRCA2 deficiency. In addition to SC-type abnormalities [quadri-radial chromosomes, breakage, tri-radial chromosomes, chromosome loss/gain (aneuploidy/polyploidy), deletions, amplifications, inversions, and translocations], BRCA2-deficient cells also exhibit (a) a deficit in HR repair of I-<italic>Sce</italic>I-induced DSBs; (b) normal efficiency of DSB repair by the error-prone, non-homologous end joining (NHEJ) pathway; (c) heightened efficiency of DSB repair by ssDNA annealing (SSA), a RAD51-independent gene deletion process restricted to DSBs generated between direct repeats; (d) hypersensitivity to MMS, HU, UV, IR and chemotherapeutic, DSB-inducing agents; (e) defective G2/M checkpoint; (f) an amplified rate of both gene mutations and reversions; (g) a hyper-recombination phenotype, characterized by an increased rate of spontaneous HR, gene conversion, inversion and deletion/amplification (crossover) events; and last but not least (h) an augmented rate of spontaneous SC replication slippage (SCRS), a RAD51-independent gene deletion/amplification process (Scully and Livingston <xref ref-type="bibr" rid="CR53">2000</xref>; Venkitaraman <xref ref-type="bibr" rid="CR61">2002</xref>; Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>; Gudmundsdottir and Ashworth <xref ref-type="bibr" rid="CR29">2006</xref>; Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>). These phenotypes are also characteristic features of BRCA1-deficient cells, except that they exhibit a deficit in DSB repair by SSA (Scully and Livingston <xref ref-type="bibr" rid="CR53">2000</xref>; Venkitaraman <xref ref-type="bibr" rid="CR61">2002</xref>; Cousineau et al. <xref ref-type="bibr" rid="CR17">2005</xref>; Gudmundsdottir and Ashworth <xref ref-type="bibr" rid="CR29">2006</xref>; Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>).</p>
      <p>These findings indicate that EMSY-overexpressing MCF-7 cells only partially mimic BRCA-deficient tumor cells. They exhibit both an enhanced rate of SCRS and decreased efficiency of HR repair of I-<italic>Sce</italic>I-induced DSBs, but show a decreased rate of spontaneous HR and normal efficiency of DSB repair by SSA, suggesting that increased EMSY level interferes with the recruitment/activation of ATR without affecting that of ATM or the processing of DSB ends into ssDNA by BRCA1/MRN or the ability of BRCA2/RAD51 to bind/stabilize ssDNA. We extensively discuss the molecular details of how this can happen, to appreciate all phenotypes of BRCA deficiency as markers of deregulated HR orchestrating at least S/G2/M-transition checkpoints and gene mutation-avoidance systems.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec id="Sec3">
        <title>DNA manipulations, cell lines, culture, and DNA transfections</title>
        <p>Three distinct recombination/repair reporter MCF-7 cell lines were transfected with pcDNA3.1<italic>Neo</italic>-based expression vector, with or without short <italic>EMSY</italic> (1&#x2013;478) (Hughes-Davies et al. <xref ref-type="bibr" rid="CR34">2003</xref>), using FuGENE 6 transfection reagent (Boehringer-Mannheim, Indianapolis, IN). Forty-eight hours later, the transfected cells were cultured in medium containing G418 (600&#xA0;&#x3BC;g/mL). Independent G418<sup>R</sup> cell clones were picked and amplified individually to analyze short <italic>EMSY</italic> integration and its expression by PCR, RT-PCR and Western blotting.</p>
      </sec>
      <sec id="Sec4">
        <title>PCR</title>
        <p>Genomic DNA was extracted from individual cell clones, and 400&#xA0;ng subjected to PCR with the following primer pair: EMSY37-F (5&#x2032;-agggatgaatgcaaaagaat-3&#x2032;) and pcDNA3.1Neo-R (5&#x2032;-tctgagatgagtttttgttc-3&#x2032;), which specifically amplifies a fragment of 1,397&#xA0;bp from exogenous <italic>EMSY</italic> but not endogenous <italic>EMSY</italic>.</p>
      </sec>
      <sec id="Sec5">
        <title>RT-PCR</title>
        <p>RNA was extracted from individual cell clones with Trizol reagent and transcribed to cDNA with reverse transcriptase and primers (hexamers) from the SuperScript First-Strand Synthesis System RT-PCR kit (Invitrogen, Carlsbad, CA). The same primer pair described for PCR was employed to amplify exogenous <italic>EMSY</italic> cDNA. In the same reaction tube, <italic>EMSY</italic>1810-R (5&#x2032;-ttttctcctccagcatttag-3&#x2032;) was added to amplify, together with <italic>EMSY</italic>37-F, a 1,773-bp fragment from endogenous wild-type (wt) <italic>EMSY</italic>. In reaction controls, the primer pair 18s-F (5&#x2032;-tgaggccatgattaagaggg-3&#x2032;) and 18s-R (5&#x2032;-cgctgagccagttcagt gtag-3&#x2032;) amplified a 642-bp fragment of ribosomal RNA. <italic>Puro</italic><sup>R</sup>, <italic>Hyg</italic><sup>R</sup>, and <italic>BRCA2</italic> expression was assessed with <italic>Puro</italic>-F (5&#x2032;-cgaccttccatgaccgagta-3&#x2032;) and <italic>Puro</italic>-R (5&#x2032;-gccttccatctgttgctg-3&#x2032;), <italic>Hyg</italic>-F (5&#x2032;-cggcgagtacttctacacagc-3&#x2032;) and <italic>Hyg</italic>-R (5&#x2032;-ttcgaacacgcagatgcagtcg-3&#x2032;), <italic>BRCA2</italic>-F (5&#x2032;-ccaagtcatgccacacattc-3&#x2032;) and <italic>BRCA2</italic>-R (5&#x2032;-ttgaccaggtgcggtaaaat-3&#x2032;). In addition, <italic>RAD51</italic> expression was analyzed with the primer pair <italic>RAD51</italic>-F (5&#x2032;-gagtaatggcaatgcagatgca-3&#x2032;) and <italic>RAD51</italic>-R (5&#x2032;tcgacccgagtagtctgttct-3&#x2032;). PCR amplifications were undertaken with the Expand High Fidelity PCR System kit (Boehringer-Mannheim).</p>
      </sec>
      <sec id="Sec6">
        <title>Protein manipulations</title>
        <p>Proteins were extracted and quantified as described previously (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>). Fifty micrograms of protein extract was separated on 8% sodium dodecyl sulfate-polyacrylamide gel, transferred to nitrocellulose membranes (Amersham, Piscataway, NJ) and probed with crude rabbit antisera (1/3,000) directed against EMSY. For RAD51 detection, 50&#xA0;&#x3BC;g of protein extracts was separated on 12.5% gel and probed with mouse anti-RAD51 antibody (51RAD01, Calbiochem, La Jolla, CA) with actin as loading control (ACTN05, Medicorp, Montreal, QC, Canada).</p>
      </sec>
      <sec id="Sec7">
        <title>HR frequency and rate</title>
        <p>HR rate and frequency were determined from at least two to three independent experiments, respectively, as described previously (Lemelin et al. <xref ref-type="bibr" rid="CR41">2005</xref>). Briefly, in each experiment and for each cell line, 12 independent cultures (1&#x2013;100 cells) were plated in parallel and cultured to confluence. Cells were trypsinized, counted, and a portion was taken for plating efficiency estimation. 5&#xA0;&#xD7;&#xA0;10<sup>5</sup> cells were plated 24&#xA0;h before adding Puro at 1.0&#xA0;&#x3BC;g/mL. Since HR between direct repeats can delete <italic>Hyg</italic><sup><italic>R</italic></sup> during culture, direct-repeat cell lines were maintained without hygromycin before Puro selection. The number of Puro<sup>R</sup> colonies divided by the number of plated cells determined HR frequency. The HR rate was calculated from these frequencies by the fluctuation test.</p>
        <p>For I-<italic>Sce</italic>I-induced HR experiments, the vectors p&#x3B2;actin<italic>SceI</italic> and pFRED25, which express the meganuclease I-<italic>Sce</italic>I and green fluorescent protein (GFP), respectively, were co-transfected into 2&#xA0;&#xD7;&#xA0;10<sup>5</sup> cells with FuGENE 6. In parallel experiments, the same number of cells was transfected with pFRED25 and pMC1<italic>Neo</italic>, the latter to correct for DNA content as a control for I-<italic>Sce</italic>I efficiency. GFP-expressing cells were counted 48&#xA0;h after transfection to examine the efficiency of transfection and normalize HR frequencies. Puro selection was performed 10&#xA0;days after transfection. The frequency of I-<italic>Sce</italic>I-induced HR was calculated by dividing the number of Puro<sup>R</sup> colonies transfected with I-<italic>Sce</italic>I by the number of Puro<sup>R</sup> colonies transfected with control DNA and normalized for transfection efficiency.</p>
      </sec>
      <sec id="Sec8">
        <title>Statistical analysis</title>
        <p>HR frequencies and rates were assessed by one-way ANOVA. For the analysis of recombination/repair pathways, contingency tables were used with the Chi-square test.</p>
      </sec>
    </sec>
    <sec id="Sec9">
      <title>Results</title>
      <sec id="Sec10">
        <title>Experimental strategy</title>
        <p>The MCF-7 cell lines employed as backgrounds for <italic>EMSY</italic> overexpression each carries a single, intact copy of a recombination/repair construct containing either a direct-repeat or an inverted-repeat of two inactive <italic>Puro</italic><sup>R</sup> genes separated by the <italic>Hyg</italic><sup>R</sup> gene (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>; Lemelin et al. <xref ref-type="bibr" rid="CR41">2005</xref>). Deleting <italic>Eag</italic>I and <italic>Bss</italic>HII restriction sites and inserting one I-<italic>Sce</italic>I cleavage site inactivated the full-length <italic>Puro</italic> gene, whereas the wt <italic>Puro</italic> gene contained an inactivating 5&#x2032; deletion, including the promoter. A recombination/repair event between the two <italic>Puro</italic> cassettes would reconstitute a functional <italic>Puro</italic><sup>R</sup> gene through loss of I-<italic>Sce</italic>I and gain of wt <italic>Eag</italic>I/<italic>Bss</italic>HII sites, restoring resistance to the drug puromycin in colony assay.<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Homologous recombination (HR) between direct and inverted repeats. HR reconstitutes a functional <italic>Puro</italic><sup>R</sup> gene through loss of the I-<italic>Sce</italic>I site and gain of <italic>Eag</italic>I/<italic>Bss</italic>HII sites. Since I-<italic>Sce</italic>I insertion mutation in <italic>ScePuro</italic> entails the deletion of <italic>Eag</italic>I and <italic>Bss</italic>HII sites, only error-free HR repair events between the two <italic>Puro</italic><sup>R</sup> cassettes can restore a functional <italic>Puro</italic> gene. Gene conversion restores one functional <italic>Puro</italic> gene without affecting the overall structure of the locus, whereas crossover associated or not with gene conversion inverts <italic>Hyg</italic><sup>R</sup> gene between inverted <italic>Puro</italic> repeats (<bold>a</bold>) or deletes <italic>Hyg</italic><sup>R</sup> between direct <italic>Puro</italic> repeats (<bold>b</bold>). Deletion events can also result from SCRS or SSA (see text)</p></caption><graphic xlink:href="438_2011_612_Fig1_HTML" id="MO1"/></fig></p>
        <p>In this type of assay system (Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>), the efficiency of recombination/repair also depends on the ability of a cell to at least survive the damage and express the reporter gene. It has been consistently demonstrated with various organisms that when more than two copies of a reporter gene lie adjacent to one another, the tandem can undergo chromatin assembly and transcription repression, an epigenetic phenomenon known as homology- or repeat-induced gene silencing (HIGS or RIGS) that resembles position-effect variegation, in which chromatin assembly can spread into adjacent domains (Henikoff <xref ref-type="bibr" rid="CR32">1998</xref>). The use of single-copy MCF-7 cell clones would thus prevent repression of <italic>Puro</italic><sup>R</sup> gene by HIGS. In addition, the <italic>Puro</italic><sup>R</sup> gene was also designed to escape repression from the adjacent marker <italic>Hyg</italic><sup>R</sup> gene (Lemelin et al. <xref ref-type="bibr" rid="CR41">2005</xref>). It has also been consistently shown in various organisms that in such cell clones, which had initially been selected for the expression of a marker gene, the adjacent reporter gene was usually repressed (Villemure et al. <xref ref-type="bibr" rid="CR64">2001</xref>; Eszterhas et al. <xref ref-type="bibr" rid="CR22">2002</xref>). Such an HIGS-independent, gene-silencing phenomenon, termed &#x2018;transcriptional interference&#x2019; and &#x2018;promoter suppression&#x2019;, can occur whether adjacent transcription units are arranged in direct or inverted orientations. Transcriptional interference/suppression is cis-acting, epigenetic and heritable. Since EMSY interacts with CAFs and its increased level represses the transcription of reporter genes (Hughes-Davies et al. <xref ref-type="bibr" rid="CR34">2003</xref>), a transcription interference/suppression-free assay system was considered necessary for this study.</p>
        <p>Nevertheless, we investigated the effect of increased EMSY level on the expression of <italic>Hyg</italic><sup>R</sup> and <italic>Puro</italic><sup>R</sup> genes at distinct loci. <italic>Hyg</italic><sup>R</sup> expression is driven by the Herpes simplex virus thymidine kinase (<italic>TK</italic>) gene promoter, whereas that of <italic>Puro</italic><sup>R</sup> is under control of the strong cellular-housekeeping phosphoglycerate kinase gene promoter (Lemelin et al. <xref ref-type="bibr" rid="CR41">2005</xref>). MCF-7 cells exhibit normal <italic>EMSY</italic> copy number and expression level, whereas overexpression of a truncated <italic>EMSY</italic> form, containing the binding sites of BRCA2, HP1&#x3B2; and BS69, represses both BRCA2<sub>ex3</sub>-transactivation potential and expression of a <italic>TK</italic> gene promoter in transient assays (Hughes-Davies et al. <xref ref-type="bibr" rid="CR34">2003</xref>). To examine this in stable MCF-7 cell clones, the three distinct reporter cell lines dA9, iA12 and iA7, grown in Hyg-free medium, were transfected with pcDNA3.1<italic>Neo</italic> containing or not short <italic>EMSY</italic> (Hughes-Davies et al. <xref ref-type="bibr" rid="CR34">2003</xref>). Since DNA transfection per se can activate DDR (Igoucheva et al. <xref ref-type="bibr" rid="CR35">2006</xref>) and DDR activation can repress both p53-dependent and -independent gene expression (Zhou et al. <xref ref-type="bibr" rid="CR81">2007</xref>), and p53 can repress all viral promoters driving the expression of reporter genes (Lemelin et al. <xref ref-type="bibr" rid="CR41">2005</xref>), independent <italic>Neo</italic><sup>R</sup> cell clones were picked, amplified and only then analyzed by PCR of genomic DNA, RT-PCR and Western blotting. Direct-repeat (dA9) and inverted-repeat (iA12 and iA7) cell lines presented similar expression levels of either endogenous or exogenous <italic>EMSY</italic> (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). However, the slight increase in EMSY protein level did not repress <italic>Hyg</italic><sup>R</sup>, since individual <italic>Neo</italic><sup>R</sup> cell clones, grown in parallel in G418- and Hyg-containing media, showed similar plating efficiency. In addition, no apparent change in <italic>Hyg</italic> or <italic>Puro</italic> expression was noted at the RNA level (data not included).<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Short <italic>EMSY</italic> expression in MCF-7 cell lines. PCR of genomic DNA was performed to demonstrate <italic>EMSY</italic> transgene integration. The primer pair employed amplifies only the <italic>EMSY</italic> transgene. Its mRNA was analyzed by qualitative RT-PCR with the same primer pair. As a control, a fragment from endogenous full-length <italic>EMSY</italic> was amplified in the same reaction.&#xA0;18S rRNA was amplified as a control for RT-PCR. Water or no reverse transcriptase served as a negative control, whereas <italic>EMSY-</italic>expressing vector DNA was used as a positive control. EMSY proteins were assessed by Western blotting. All the different EMSY cell lines examined are independent cell clones</p></caption><graphic xlink:href="438_2011_612_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec11">
        <title>Short EMSY represses spontaneous RAD51-mediated HR</title>
        <p>One can envisage at least four more mechanisms by which short EMSY may affect spontaneous HR (i.e., without exposure to exogenous DNA-damaging agents). First, it may override PALB2 and thereby target BRCA2 for degradation in a manner similar to PALB2 depletion (Xia et al. <xref ref-type="bibr" rid="CR73">2006</xref>). Second, it may induce a BRCA2 conformational change that may affect its ability to interact and/or co-localize with RAD51, DSS1, or FANC-D2 at sites of DNA damage (Gudmundsdottir and Ashworth <xref ref-type="bibr" rid="CR29">2006</xref>). These proteins interact with the BRCA2 C-terminal domain, and deletion of such a domain or disruption of its interacting proteins has been shown to mimic <italic>BRCA2</italic> deficiency, as revealed by decreased efficiency of HR repair of I-<italic>Sce</italic>I-induced DSBs and hypersensitivity to PARP1 inhibitors and DSB-inducing agents (Gudmundsdottir and Ashworth <xref ref-type="bibr" rid="CR29">2006</xref>; Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>). In addition, deletion of the human BRCA2 C-terminal domain also increases the rate of spontaneous HR (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>). Thus, in either scenario, <italic>EMSY</italic>-overexpressing cell lines would exhibit all these phenotypes, as BRCA2-deficient CAPAN-1 cells do (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>).</p>
        <p>Third, short EMSY may directly repress the expression of <italic>RAD51</italic> gene or its transactivator <italic>PTEN</italic>, since cells depleted of <italic>PTEN</italic> also undergo SC-type abnormalities similar to <italic>RAD51</italic>-deficient cells (Shen et al. <xref ref-type="bibr" rid="CR54">2007</xref>), BRCA2-deficient cells (Venkitaraman <xref ref-type="bibr" rid="CR61">2002</xref>) or short <italic>EMSY</italic>-expressing cells (Raouf et al. <xref ref-type="bibr" rid="CR52">2005</xref>). Fourth, it may override PALB2 and RPA, and thereby quench BRCA2 without affecting its stability. In these two scenarios, short <italic>EMSY</italic>-expressing cells would be expected to exhibit a hypo-recombination phenotype by decreasing the rate of spontaneous HR.</p>
        <p>To examine which scenario is more likely, single Neo<sup>R</sup>/Hyg<sup>R</sup>, inverted-repeat MCF-7 cell clones and EMSY-overexpressing derivatives were grown in parallel and subjected to Puro selection. In contrast to direct repeats, inverted repeats monitor exclusively RAD51-mediated HR: gene conversion and crossover (inversion) events (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). EMSY-overexpressing MCF-7 cell lines displayed 4&#x2013;16-fold decreases in the rate of spontaneous HR, compared to their parental cell lines containing the empty vector (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). In addition, no apparent difference in <italic>RAD51</italic> or <italic>BRCA2</italic> gene expression was noted between parental and derivative cell lines (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). Since BRCA2 can bind only 20% of the cellular RAD51 pool (Marmorstein et al. <xref ref-type="bibr" rid="CR44">1998</xref>; Yu et al. <xref ref-type="bibr" rid="CR77">2003</xref>), these findings indicate that short EMSY repressed at least free RAD51 molecules.<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Effect of EMSY on spontaneous inverted-repeat HR</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Cell lines</th><th align="left">Frequency<sup>a</sup></th><th align="left">Ratio<sup>b</sup></th><th align="left">Rate<sup>c</sup></th><th align="left">Ratio<sup>d</sup></th></tr></thead><tbody><tr><td align="left">iA7</td><td align="left">2.05&#xA0;&#xB1;&#xA0;0.7&#xA0;&#xD7;&#xA0;10<sup>&#x2212;4</sup></td><td align="left"/><td align="left">4.94&#xA0;&#xB1;&#xA0;0.7&#xA0;&#xD7;&#xA0;10<sup>&#x2212;5</sup></td><td align="left"/></tr><tr><td align="left">iA7/EMSY-3B</td><td align="left">3.25&#xA0;&#xB1;&#xA0;1.6&#xA0;&#xD7;&#xA0;10<sup>&#x2212;5</sup></td><td char="." align="char">6.3</td><td align="left">7.97&#xA0;&#xB1;&#xA0;1.0&#xA0;&#xD7;&#xA0;10<sup>&#x2212;6</sup></td><td char="." align="char">6.2</td></tr><tr><td align="left">iA7/EMSY-6</td><td align="left">2.86&#xA0;&#xB1;&#xA0;1.4&#xA0;&#xD7;&#xA0;10<sup>&#x2212;5</sup></td><td char="." align="char">7.2</td><td align="left">7.24&#xA0;&#xB1;&#xA0;0.9&#xA0;&#xD7;&#xA0;10<sup>&#x2212;6</sup></td><td char="." align="char">6.8</td></tr><tr><td align="left">iA7/EMSY-9</td><td align="left">5.61&#xA0;&#xB1;&#xA0;2.9&#xA0;&#xD7;&#xA0;10<sup>&#x2212;5</sup></td><td char="." align="char">3.7</td><td align="left">1.14&#xA0;&#xB1;&#xA0;0.4&#xA0;&#xD7;&#xA0;10<sup>&#x2212;5</sup></td><td char="." align="char">4.3</td></tr><tr><td align="left">iA7/EMSY-31</td><td align="left">1.30&#xA0;&#xB1;&#xA0;0.5&#xA0;&#xD7;&#xA0;10<sup>&#x2212;5</sup></td><td char="." align="char">15.8</td><td align="left">3.33&#xA0;&#xB1;&#xA0;0.8&#xA0;&#xD7;&#xA0;10<sup>&#x2212;6</sup></td><td char="." align="char">14.8</td></tr><tr><td align="left">iA12</td><td align="left">2.24&#xA0;&#xB1;&#xA0;1.0&#xA0;&#xD7;&#xA0;10<sup>&#x2212;3</sup></td><td align="left"/><td align="left">3.25&#xA0;&#xB1;&#xA0;1.0&#xA0;&#xD7;&#xA0;10<sup>&#x2212;4</sup></td><td align="left"/></tr><tr><td align="left">iA12/EMSY-13</td><td align="left">2.76&#xA0;&#xB1;&#xA0;1.1&#xA0;&#xD7;&#xA0;10<sup>&#x2212;4</sup></td><td char="." align="char">8.1</td><td align="left">4.83&#xA0;&#xB1;&#xA0;1.2&#xA0;&#xD7;&#xA0;10<sup>&#x2212;5</sup></td><td char="." align="char">6.7</td></tr><tr><td align="left">iA12/EMSY-18</td><td align="left">9.73&#xA0;&#xB1;&#xA0;2.3&#xA0;&#xD7;&#xA0;10<sup>&#x2212;5</sup></td><td char="." align="char">23.0</td><td align="left">2.03&#xA0;&#xB1;&#xA0;0.6&#xA0;&#xD7;&#xA0;10<sup>&#x2212;5</sup></td><td char="." align="char">16.0</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Frequency is determined as the number of Puro<sup>R</sup> cell clones relative to the total number of viable cells before selection</p><p><sup>b</sup>Ratio (parent/EMSY-expressing derivative cell lines) indicates recombination fold decrease in EMSY-expressing cells relative to their parents (<italic>p</italic>&#xA0;&lt;&#xA0;0.0001)</p><p><sup>c</sup>Rate represents the number of recombination events/locus/cell/generation</p><p><sup>d</sup>Ratio (parent/EMSY-expressing derivative cell lines) (iA7, <italic>p</italic>&#xA0;=&#xA0;0.0003; iA12, <italic>p</italic>&#xA0;=&#xA0;0.0236)</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Effect of short EMSY on <italic>BRCA2</italic> and <italic>RAD51</italic> expression. RT-PCR reveals no apparent effect of short EMSY on <italic>RAD51</italic> or <italic>BRCA2</italic> expression levels. 18S rRNA was amplified as a control for RT-PCR. Water or no reverse transcriptase was a negative control. Western blotting analysis indicates no apparent effect of short EMSY on RAD51 protein level. Actin served as loading control</p></caption><graphic xlink:href="438_2011_612_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec12">
        <title>Short EMSY heightens the rate of spontaneous SCRS</title>
        <p>If short EMSY were to suppress spontaneous HR by interfering solely with free RAD51 molecules, one would expect no effect on SCRS, since the process is RAD51-independent and yet down-regulated by both BRCA1 and BRCA2 (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>; Cousineau et al. <xref ref-type="bibr" rid="CR17">2005</xref>). To examine this, we tested direct-repeat cell lines that monitor a mixture of HR and SCRS (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). However, short EMSY did not affect the rate of <italic>Puro</italic><sup>R</sup> colony formation with direct repeats, but significantly shifted gene conversion to deletion events (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>), as revealed by PCR analysis of the recombinants (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>). The increase in deletion cannot be attributed to augmented crossover, since short EMSY represses such HR events at inverted repeats (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). In addition, neither BRCA2 nor BRCA1 represses crossover in favour of gene conversion as the RAD51-interacting BLM or WRN helicase does with HR intermediates containing crossed DNA strands: Holliday junctions (HJs) (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>; Cousineau et al. <xref ref-type="bibr" rid="CR17">2005</xref>). Collectively, these findings indicate that short EMSY not only interferes with free RAD51 molecules and BRCA2/RAD51 complexes, but also disrupts SCC/alignment.<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Effect of EMSY on spontaneous direct-repeat HR</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Cell lines</th><th align="left">Frequency</th><th align="left">Ratio</th><th align="left">Rate</th><th align="left">Ratio</th><th align="left">GC (%)</th><th align="left">SCRS (%)</th></tr></thead><tbody><tr><td align="left">dA9</td><td align="left">2.99&#xA0;&#xB1;&#xA0;0.8&#xA0;&#xD7;&#xA0;10<sup>&#x2212;6</sup></td><td align="left"/><td align="left">6.56&#xA0;&#xB1;&#xA0;0.9&#xA0;&#xD7;&#xA0;10<sup>&#x2212;7</sup></td><td align="left"/><td align="left">34/36 (94)</td><td align="left">2/36 (6)</td></tr><tr><td align="left">dA9/EMSY-7</td><td align="left">2.30&#xA0;&#xB1;&#xA0;0.9&#xA0;&#xD7;&#xA0;10<sup>&#x2212;6</sup></td><td char="." align="char">1.3</td><td align="left">5.31&#xA0;&#xB1;&#xA0;0.8&#xA0;&#xD7;&#xA0;10<sup>&#x2212;7</sup></td><td char="." align="char">1.2</td><td align="left">12/14 (86)</td><td align="left">2/14 (14)</td></tr><tr><td align="left">dA9/EMSY-9</td><td align="left">2.32&#xA0;&#xB1;&#xA0;0.7&#xA0;&#xD7;&#xA0;10<sup>&#x2212;6</sup></td><td char="." align="char">1.3</td><td align="left">5.35&#xA0;&#xB1;&#xA0;0.9&#xA0;&#xD7;&#xA0;10<sup>&#x2212;7</sup></td><td char="." align="char">1.2</td><td align="left">9/11 (82)</td><td align="left">2/11 (18)</td></tr><tr><td align="left">dA9/EMSY-16</td><td align="left">2.87&#xA0;&#xB1;&#xA0;0.7&#xA0;&#xD7;&#xA0;10<sup>&#x2212;6</sup></td><td char="." align="char">1.0</td><td align="left">5.72&#xA0;&#xB1;&#xA0;0.7&#xA0;&#xD7;&#xA0;10<sup>&#x2212;7</sup></td><td char="." align="char">1.1</td><td align="left">25/33 (76)</td><td align="left">8/33 (24)</td></tr><tr><td align="left">dA9/EMSY-19</td><td align="left">2.55&#xA0;&#xB1;&#xA0;1.0&#xA0;&#xD7;&#xA0;10<sup>&#x2212;6</sup></td><td char="." align="char">1.2</td><td align="left">5.84&#xA0;&#xB1;&#xA0;0.7&#xA0;&#xD7;&#xA0;10<sup>&#x2212;7</sup></td><td char="." align="char">1.1</td><td align="left">56/92 (61)</td><td align="left">36/92 (39)</td></tr><tr><td align="left">dA9/EMSY-20</td><td align="left">3.17&#xA0;&#xB1;&#xA0;1.4&#xA0;&#xD7;&#xA0;10<sup>&#x2212;6</sup></td><td char="." align="char">0.9</td><td align="left">6.84&#xA0;&#xB1;&#xA0;1.0&#xA0;&#xD7;&#xA0;10<sup>&#x2212;7</sup></td><td char="." align="char">1.0</td><td align="left">23/30 (77)</td><td align="left">7/30 (23)</td></tr></tbody></table><table-wrap-foot><p>Frequencies, rates and ratios were determined as described in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref></p><p><italic>GC</italic> gene conversion</p><p>The apparent absence of EMSY effect on the frequency (<italic>p</italic>&#xA0;=&#xA0;0.93) and rate (<italic>p</italic>&#xA0;=&#xA0;0.43) of spontaneous Puro<sup>R</sup> colony formation appears to be due to a decrease in RAD51-mediated GC events compensated by an increase in RAD51-independent SCRS events (<italic>p</italic>&#xA0;=&#xA0;0.004)</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec13">
        <title>Short EMSY represses BRCA2/RAD51-mediated HR repair of DSBs</title>
        <p>To examine this, direct-repeat MCF-7 cell lines and EMSY-overexpressing derivatives were transiently co-transfected in parallel with the p&#x3B2;actin/I-<italic>Sce</italic>I vector, which expresses I-<italic>Sce</italic>I, and a GFP-expressing vector, employed to evaluate transfection efficiency. No apparent difference in cell viability was noted after transfection between the parental cell line and <italic>EMSY</italic>-overexpressing derivatives (data not included). When the <italic>Puro</italic> gene is cleaved at the I-<italic>Sce</italic>I site, HR repairs the DSB (Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>). I-<italic>Sce</italic>I expression increases the frequency of Puro<sup>R</sup> colony formation with all cell lines, whereas EMSY-overexpressing derivatives consistently present threefold fewer colonies than their parents do (Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table&#xA0;3</label><caption><p>Effect of EMSY on I-<italic>Sce</italic>I-induced HR</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Cell lines</th><th align="left">Frequency<sup>a</sup></th><th align="left">Ratio<sup>b</sup></th><th align="left">GC (%)<sup>c</sup></th><th align="left">SSA (%)</th></tr></thead><tbody><tr><td align="left">dA9</td><td char="&#xB1;" align="char">217.63&#xA0;&#xB1;&#xA0;67.6</td><td align="left"/><td align="left">68/74 (92)</td><td align="left">6/74 (8)</td></tr><tr><td align="left">dA9/EMSY-7</td><td char="&#xB1;" align="char">81.32&#xA0;&#xB1;&#xA0;40.3</td><td char="." align="char">2.7</td><td align="left">53/68 (78)</td><td align="left">15/68 (22)</td></tr><tr><td align="left">dA9/EMSY-9</td><td char="&#xB1;" align="char">75.59&#xA0;&#xB1;&#xA0;38.5</td><td char="." align="char">2.9</td><td align="left">66/90 (73)</td><td align="left">24/90 (27)</td></tr><tr><td align="left">dA9/EMSY-16</td><td char="&#xB1;" align="char">70.21&#xA0;&#xB1;&#xA0;21.3</td><td char="." align="char">3.1</td><td align="left">52/66 (79)</td><td align="left">14/66 (21)</td></tr><tr><td align="left">dA9/EMSY-19</td><td char="&#xB1;" align="char">71.64&#xA0;&#xB1;&#xA0;33.0</td><td char="." align="char">3.0</td><td align="left">55/78 (71)</td><td align="left">23/78 (29)</td></tr><tr><td align="left">dA9/EMSY-20</td><td char="&#xB1;" align="char">82.45&#xA0;&#xB1;&#xA0;37.2</td><td char="." align="char">2.6</td><td align="left">47/58 (81)</td><td align="left">11/58 (19)</td></tr></tbody></table><table-wrap-foot><p><italic>GC</italic> gene conversion, <italic>SSA</italic> single-strand annealing</p><p><sup>a</sup>Frequency fold induction represents the mean of at least three independent experiments for each cell line (<italic>p</italic>&#xA0;=&#xA0;0.0064)</p><p><sup>b</sup>Ratio indicates recombination fold decrease in EMSY-expressing cells relative to their parents</p><p><sup>c</sup>EMSY shifts the proportion of GC events to SSA (<italic>p</italic>&#xA0;=&#xA0;0.029); the absolute value of SSA events remained unchanged but their proportion increased in comparison to the decreased number of GC events</p></table-wrap-foot></table-wrap></p>
        <p>HR repair of I-<italic>Sce</italic>I-induced DSBs between direct repeats occurs almost exclusively by gene conversion with few deletion events attributed to SSA (Cousineau and Belmaaza <xref ref-type="bibr" rid="CR18">2007</xref>; Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>). SSA, which obligatorily leads to deletion between direct repeats, cannot be monitored with inverted repeats, since the processing of DSB ends by BRCA1/MRN and ATM would generate identical rather than complementary ssDNA ends that would anneal (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Consistent with BRCA2/RAD51 complexes acting downstream of BRCA1/MRN (Greenberg et al. <xref ref-type="bibr" rid="CR27">2006</xref>; Zhang et al. <xref ref-type="bibr" rid="CR79">2009</xref>; Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>), the efficiency of DSB repair by SSA decreases in BRCA1-deficient cells and increases in RAD51- or BRCA2-deficient cells at the expense of reduced gene conversion (Daboussi et al. <xref ref-type="bibr" rid="CR19">2002</xref>; Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>; Cousineau et al. <xref ref-type="bibr" rid="CR17">2005</xref>; Gudmundsdottir and Ashworth <xref ref-type="bibr" rid="CR29">2006</xref>). To determine whether short EMSY also affected DSB repair by SSA, we investigated the structure of I-<italic>Sce</italic>I-induced recombinants by PCR (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>). Taking into consideration the threefold decrease in the overall frequency of I-<italic>Sce</italic>I-induced HR, PCR analysis indicates that short EMSY lowers the efficiency of gene-conversion repair by 3.7-fold and shifts DSB repair from gene conversion to SSA, without affecting the efficiency of the latter (Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>).</p>
      </sec>
    </sec>
    <sec id="Sec14">
      <title>Discussion</title>
      <p>Briefly, our findings indicate that an increased level of the EMSY N-terminal domain only partially mimics BRCA2 deficiency. Similar to BRCA2-deficient CAPAN-1 cells (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>), EMSY-overexpressing MCF-7 cells also exhibit an increased rate of SCRS and a deficit in HR repair of I-<italic>Sce</italic>I-induced DSBs. However, unlike CAPAN-1 cells that present an increased rate of spontaneous HR and heightened efficiency of DSB repair by SSA (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>), EMSY-overexpressing MCF-7 cells rather display a decreased rate of the former and normal efficiency of the latter.</p>
      <p>The differential effect of short EMSY on these processes, together with the lack of influence on expression of the reporter genes <italic>Hyg</italic> and <italic>Puro</italic> at three distinct loci and endogenous <italic>RAD51</italic>, <italic>BRCA2</italic> and <italic>EMSY</italic>, seems to argue against EMSY as a general chromatin-assembly factor/transcription repressor. The lack of effect on gene expression could not be attributed to the slight elevation of EMSY level in MCF-7 cell lines, as a higher level of a similar truncated form of <italic>EMSY</italic> in a telomerase-immortalized human breast epithelial cell line also does not affect <italic>BRCA2</italic>, <italic>BRCA1</italic>, <italic>p53</italic> or <italic>p21</italic> expression (Raouf et al. <xref ref-type="bibr" rid="CR52">2005</xref>). In addition, it also does not much affect the stability of BRCA2 protein or its ability to interact and/or co-localize with RAD51, since this would confer hyper-recombination as BRCA2 deficiency does (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>). Rather, short EMSY bestows hypo-recombination by decreasing the rate of spontaneous HR, presumably by enhancing the repressive effect of BRCA2 on RAD51 (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>).</p>
      <p>Both the promotion of RAD51 activity by BRCA2 in response to I-<italic>Sce</italic>I-induced DSBs and its repression in the absence of such lethal damage were thought to be orchestrated by BRCA1, ATR and ATM (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>; Cousineau et al. <xref ref-type="bibr" rid="CR17">2005</xref>). Consistent with this view are the findings that, in undamaged human cells, the BRCA2 C-terminal RAD51-binding motif ser3291 encoded by exon27 (BRCA2<sub>ex27</sub>) is phosphorylated by CDK1, a post-translational modification that blocks its interaction with RAD51 (Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>). However, after the induction of DSBs that inactivate CDK1, BRCA2<sub>ex27</sub> becomes de-phosphorylated, and its ability to both bind RAD51 and carry out HR repair of such lethal damage is restored (Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>). RAD51 is functional as oligomers (1 oligomer contains 6 or 7 RAD51 monomers) that coat 3&#x2032;-ssDNA and form a nucleoprotein filament that undertakes the DNA strand-exchange reaction by invading an intact homologous DNA (dsDNA) to prime new DNA synthesis and thus repair the damage (Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>). Whereas the eight BRC repeats encoded by exon 11 (BRCA2<sub>ex11</sub>) can bind both RAD51 monomers and oligomers, BRCA2<sub>ex27</sub>, which is unrelated to BRC repeats, exclusively binds RAD51 oligomers or RAD51 filament (Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>). Since BRCA2 can bind only 20% of the cellular RAD51 pool (Marmorstein et al. <xref ref-type="bibr" rid="CR44">1998</xref>; Yu et al. <xref ref-type="bibr" rid="CR77">2003</xref>), one way by which short EMSY could repress both spontaneous HR and HR repair of DSBs is to both disrupt RAD51 oligomers into monomers and maintain BRCA2<sub>ex27</sub> phosphorylation.</p>
      <p>EMSY-overexpressing MCF-7 cells exhibit approximately a fourfold decrease in the efficiency of HR repair of I-<italic>Sce</italic>I-induced DSBs similar to BRCA1- or BRCA2-deficient tumor cells (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>; Cousineau et al. <xref ref-type="bibr" rid="CR17">2005</xref>), or hypoxic human cells, since hypoxia also decreases the synthesis of HR proteins to offset chemo- and radio-resistances (Chan et al. <xref ref-type="bibr" rid="CR13">2008</xref>). Consistently, a similar decrease has also been reported with cells repressed or disrupted in BARD1 (Westermark et al. <xref ref-type="bibr" rid="CR71">2003</xref>); MRN (Yang et al. <xref ref-type="bibr" rid="CR75">2006</xref>); BRIP1 (BRCA1-interacting protein, also known as the helicase BACH1) (Litman et al. <xref ref-type="bibr" rid="CR42">2005</xref>); CtIP that links BRCA1 to MRN (Chen et al. <xref ref-type="bibr" rid="CR14">2008</xref>); ATM (Golding et al. <xref ref-type="bibr" rid="CR26">2004</xref>); ATR (Wang et al. <xref ref-type="bibr" rid="CR67">2004</xref>); CHK2 (Zhang et al. <xref ref-type="bibr" rid="CR80">2004</xref>); CHK1 (Sorensen et al. <xref ref-type="bibr" rid="CR57">2005</xref>); PALB2 (Xia et al. <xref ref-type="bibr" rid="CR73">2006</xref>); RPA (Sleeth et al. <xref ref-type="bibr" rid="CR56">2007</xref>); or RAD51 (Daboussi et al. <xref ref-type="bibr" rid="CR19">2002</xref>). Since short EMSY neither represses the expression of HR reporter genes nor affects SSA efficiency, the fourfold decrease in HR repair of I-<italic>Sce</italic>I-induced DSBs cannot be ascribed to chromatin assembly diminishing DNA accessibility to transcription factors and restriction enzymes (Villemure et al. <xref ref-type="bibr" rid="CR64">2001</xref>). Rather, it could be due to either reduced efficiency of RAD51-mediated DNA strand-exchange/invasion or I-<italic>Sce</italic>I-induced cell death (apoptosis) or permanent cell-cycle arrest (senescence), in which case the essential role of HR in cell survival would be at least checkpoint rather than DSB repair per se. Consistent with this view, (a) all these HR mutant cells are hypersensitive to DSB-inducing agents that activate p53-dependent or independent apoptosis/senescence; (b) after p53 disruption or repression, the efficiency of HR repair of I-<italic>Sce</italic>I-induced DSBs increases by up to 20-fold, whereas the rate of spontaneous HR remains unchanged in the absence of such lethal damage (Akyuz et al. <xref ref-type="bibr" rid="CR3">2002</xref>; Lemelin et al. <xref ref-type="bibr" rid="CR41">2005</xref>); and (c) similar to BRCA1, both BRCA2 and RAD51 bind p53, and BRCA2/RAD51 complex represses the expression of p53-responsive genes in transient assays (Marmorstein et al. <xref ref-type="bibr" rid="CR44">1998</xref>). In such assays, DNA transfection per se can activate DDR, specifically the ATR/ATM pathway (Igoucheva et al. <xref ref-type="bibr" rid="CR35">2006</xref>), and DDR activation can repress both p53-dependent and independent gene expression (Zhou et al. <xref ref-type="bibr" rid="CR81">2007</xref>), and p53 can repress not only cellular genes but also all viral promoters that drive the expression of HR/transcription-reporter genes (Lemelin et al. <xref ref-type="bibr" rid="CR41">2005</xref>). Thus, since the I-<italic>Sce</italic>I assay system does not discriminate between checkpoint/repair and apoptosis/senescence, short EMSY may affect all DDR aspects.</p>
      <p>However, short EMSY does not seem to interfere with the localization of activated ATM, the processing of DSB ends into ssDNA by BRCA1/MRN or the stability of ssDNA ends. If it were to negatively affect any of these processes, one would have expected a similar decrease in the efficiency of DSB repair by SSA, which also requires all these HR proteins, except BRCA2/RAD51 complex that would shift DSB repair from SSA to gene conversion (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>; Gudmundsdottir and Ashworth <xref ref-type="bibr" rid="CR29">2006</xref>; Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>). Rather, short EMSY shifted DSB repair from gene conversion to SSA without affecting the efficiency of the latter. Thus, it seems that short EMSY interferes with free RAD51 molecules and the loading of RAD51 oligomers by BRCA2<sub>ex27</sub> at least at DSBs (Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>), without affecting the ability of BRCA2/RAD51 to bind/stabilize ssDNA and promote SSA.</p>
      <p>The SSA-promoting activity of BRCA2 has been appreciated with human full-length BRCA2 in CAPAN-1 cells (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>), and with its mini-homologs Brh2 in the smut, yeast-like fungus <italic>Ustilago maydis</italic> and CeBRC2 in <italic>C. elegans</italic> (Petalcorin et al. <xref ref-type="bibr" rid="CR50">2006</xref>; Mazloum et al. <xref ref-type="bibr" rid="CR45">2007</xref>). However, evidence indicates that in mammals, the SSA-promoting activity of BRCA2 may be overshadowed in the context of at least RPA/BRCA2/RAD51 complex and may become apparent only after the loss of either component of this complex. (a) In RAD51-disrupted cells that exhibit increased efficiency of SSA at I-<italic>Sce</italic>I-induced DSBs (Daboussi et al. <xref ref-type="bibr" rid="CR19">2002</xref>), RPA/BRCA2 could still bind/stabilize ssDNA ends and promote SSA, given that similar to RPA and RAD51, BRCA2 also binds ssDNA, its C-terminal domain contains both ssDNA and dsDNA-binding motifs (Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>). (b) Likewise, in BRCA2-disrupted cells that also display heightened efficiency of SSA at I-<italic>Sce</italic>I-induced DSBs (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>; Gudmundsdottir and Ashworth <xref ref-type="bibr" rid="CR29">2006</xref>), RPA/RAD51 could still bind ssDNA ends and promote SSA. However, in this case, the ability of RAD51 alone to bind and displace RPA from ssDNA and form RAD51 filament to carry out DNA strand-exchange/invasion, as it does in vitro (Stauffer and Chazin <xref ref-type="bibr" rid="CR58">2004</xref>) and in CAPAN-1 cells causing hyper-recombination (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>), is crippled by I-<italic>Sce</italic>I-induced DSBs (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>). In response to DSBs, ATM and its BRCA1-interacting tyrosine kinase c-ABL, another downstream target of DNA-PK, as well as ATR proximal kinase CHK1, each phosphorylates RAD51 (Daboussi et al. <xref ref-type="bibr" rid="CR19">2002</xref>; Shiloh <xref ref-type="bibr" rid="CR55">2003</xref>; Sorensen et al. <xref ref-type="bibr" rid="CR57">2005</xref>).</p>
      <p>It has been shown that RAD51 phosphorylation cripples the ability of RAD51 to both bind ssDNA and undertake DNA strand-exchange/invasion in vitro and HR repair of I-<italic>Sce</italic>I-induced chromosomal DSBs, presumably by disrupting RAD51 oligomers into monomers and preventing RAD51 oligomerization (Yuan et al. <xref ref-type="bibr" rid="CR78">1998</xref>; Daboussi et al. <xref ref-type="bibr" rid="CR19">2002</xref>; Conilleau et al. <xref ref-type="bibr" rid="CR16">2004</xref>). Thus, in response to DSBs, RAD51 phosphorylation would affect not only its function but also that of BRCA2, since de-phosphorylated BRCA2<sub>ex27</sub> exclusively binds RAD51 oligomer but not RAD51 monomers (Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>), raising the question: how does BRCA2/RAD51 complex conduct HR repair of DSBs? Since none of the models proposed for HR in general or for BRCA1/2 function in particular considers such a conundrum, we propose that BRCA2 may have the ability to protect its RAD51 monomers bound by the BRC repeats (exon 11) against phosphorylation (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>) (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>a).<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>A model for the BRCA2/RAD51 pathway in response to DSBs. Not all proteins and protein&#x2013;protein interactions are shown and the outlines are for illustration only. <bold>a</bold> After their recruitment by BRCA1/MRN, BRCA2/RAD51 complexes act upstream and downstream of ATR (see text for details). <bold>b</bold> After disruption of nucleosomes and transformation of DSB ends into ssDNA by BRCA1/MRN and ATM (<italic>1</italic>), RPA/BRCA2/RAD51 recruits ATR (<italic>2</italic>) to enhance SCC/alignment before the formation/stabilization of D-loop at which the 3&#x2032;-ssDNA end primes new DNA synthesis (<italic>3</italic>). ATR recruitment/activation could also occur during or after strand invasion and D-loop formation/stabilization, since transformation of DSB ends into 3&#x2032;-ssDNA could be performed by the unwinding activity of MRN rather than its exonuclease activity that normally yields 5&#x2032;-ssDNA ends. In this case, unwinding, strand invasion and D-loop formation/stabilization could occur simultaneously after the search for homology, alignment/pairing between DSB ends and the intact homologous dsDNA partner. In either case, the resulting intermediate can either disassemble, the newly synthesized strand can be displaced by unwinding to anneal with the non-invading 3&#x2032;-ssDNA end to elicit non-crossover gene conversion only, or be processed to yield gene conversion with or without crossover (<italic>4</italic>). Short EMSY interferes with ATR recruitment/activation by overriding RPA (<italic>5</italic>), without affecting the ability of BRCA2/RAD51 to bind ssDNA and perform SSA (<italic>6</italic>). At D-loops, such as at gene promoters and replication origins, free RAD51 oligomers could also compete with RNA and DNA polymerases for ssDNA and thereby block initiation of transcription, replication and repair until activation/recruitment of PIKKs that would disrupt RAD51 oligomers into monomers. The loading of RAD51 oligomers by BRCA2<sub>ex27</sub> on ssDNA may also act similarly until disruption of RAD51 filament by post-translational modifications (i.e., phosphorylation, ubiquitylation, sumoylation) that would allow transcription, replication and repair to proceed and thereby resume cell-cycle arrest. In this case, transcription and replication factors could act as cellular GPS (guiding position system) elements, recruiting checkpoint proteins to specific sites. Such BRCA2/RAD51 transcription/replication-checkpoint function could explain why checkpoint-deficient cells exhibit radio-resistant DNA synthesis, a characteristic feature of CIN syndromes, including BRCA-deficiency (see text). Thus, whereas RAD51 oligomer can act as a transcription/replication/repair repressor upstream of PIKKs, BRCA2/RAD51 complex can behave as both an activator and a repressor upstream and downstream of PIKKs, respectively</p></caption><graphic xlink:href="438_2011_612_Fig4_HTML" id="MO4"/></fig></p>
      <p>(c) In the absence of RPA, BRCA2/RAD51 could still bind/stabilize ssDNA and promote SSA. Consistently, in in vitro assays, the BRCA2 C-terminal domain, Brh2 or CeBRC2 can displace RPA from ssDNA, load RAD51 oligomer onto the dsDNA&#x2013;ssDNA junction that mimics one processed DSB end, and promote SSA between RAD51 filament and its complementary ssDNA, provided as linear, circular or embedded in synthetic D-loops (Petalcorin et al. <xref ref-type="bibr" rid="CR50">2006</xref>; Mazloum et al. <xref ref-type="bibr" rid="CR45">2007</xref>; Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>; Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>b).</p>
      <p>Since short EMSY does not seem to negatively affect the SSA-promoting activity of BRCA2/RAD51, it must have then interfered at least with the loading of RAD51 oligomer by BRCA2 (Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>). However, the loading of RAD51 oligomer by BRCA2 at DSBs cannot occur before recruitment/activation of ATR, since BRCA2<sub>ex27</sub> would be still phosphorylated by CDK1. Then, the supply of RAD51 oligomers for RAD51 filament formation could originate afterwards from the BRC repeats of RPA/BRCA2/RAD51, EMSY/BRCA2/RAD51 and PALB2/BRCA2/RAD51, with each complex providing eight non-phosphorylated RAD51 monomers and, thus, a total of three to four RAD51 oligomers. This may be sufficient for HR repair, given previous demonstrations that only one DSB end can invade the undamaged template and prime new DNA synthesis, whereas the other DSB end can capture the displaced, newly synthesized DNA strand through SSA (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>b) or NHEJ under certain circumstances, culminating in deletion, insertion, or amplification events (Belmaaza and Chartrand <xref ref-type="bibr" rid="CR6">1994</xref>; Villemure et al. <xref ref-type="bibr" rid="CR63">1997</xref>, <xref ref-type="bibr" rid="CR62">2003</xref>). Thus, by overriding at least RPA, short EMSY could block the recruitment/activation of ATR, not only at stalled forks&#x2014;increasing the likelihood of their collapse into DSBs (Raouf et al. <xref ref-type="bibr" rid="CR52">2005</xref>) as BRCA2 deficiency does (Lomonosov et al. <xref ref-type="bibr" rid="CR43">2003</xref>)&#x2014;but also at such DSBs without affecting the localization of ATM or the processing of DSBs into ssDNA ends by BRCA1/MRN. This would decrease SCC/alignment, induce RAD51 phosphorylation, and maintain BRCA2<sub>ex27</sub> phosphorylation, thereby increasing SCRS and repressing both spontaneous HR and HR repair of DSBs without affecting SSA, as found to be the case.</p>
      <p>That EMSY/BRCA2, RPA/BRCA2 and PALB2/BRCA2 complexes have independently been fractionated from undamaged human cells indicates that, similar to PALB2, EMSY and RPA are also partners and stabilizers of BRCA2 (Hughes-Davies et al. <xref ref-type="bibr" rid="CR34">2003</xref>; Wong et al. <xref ref-type="bibr" rid="CR72">2003</xref>; Xia et al. <xref ref-type="bibr" rid="CR73">2006</xref>). However, regardless of their proportions in cells, increased EMSY level would be expected to shift protein concentration equilibrium towards EMSY/BRCA2, overriding PALB2 and RPA by quenching BRCA2 without affecting its overall stability. As it still interacts with HP1&#x3B2; and BS69, short EMSY might also override full-length EMSY. However, notwithstanding the exact role of full-length EMSY, the effects of short EMSY reported here provide evidence that, in addition to chromatin and transcription regulation, BRCA2<sub>ex3</sub> may also be directly involved in the development of DDR in at least replication/checkpoint and recombination/repair.</p>
      <p>Such a heretofore unappreciated function of BRCA2 can be best examined in phenotypes of <italic>BRCA2</italic> knockout (KO) mice. Whereas <italic>BRCA2</italic> null, <italic>BRCA2</italic><sup>&#x394;ex1&#x2212;5</sup> and <italic>BRCA2</italic><sup>&#x394;ex11</sup> KO mice all die at an early embryonic stage in a manner similar to <italic>RPA</italic> and <italic>RAD51</italic> KO mice, <italic>BRCA2</italic><sup>&#x394;ex27</sup> KO mice are viable and develop normally (Donoho et al. <xref ref-type="bibr" rid="CR21">2003</xref>; Evers and Jonkers <xref ref-type="bibr" rid="CR23">2006</xref>; Friedberg and Meira <xref ref-type="bibr" rid="CR25">2006</xref>), indicating that whereas the function of at least BRCA2<sub>ex3</sub> and BRCA2<sub>ex11</sub> in replication/checkpoint is essential, that of BRCA2<sub>ex27</sub> in RAD51-mediated HR repair of DSBs and resistance to DSB-induced lethality (Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>; Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>) is dispensable for cell survival, proliferation and differentiation. The embryonic lethality of <italic>BRCA2</italic> KO mice has been associated with chromosomal breakage and activation of p53, suggesting that: (a) such lethal damage does not arise accidentally in <italic>BRCA2</italic><sup>&#x394;ex27</sup> KO mice or normal proliferating/differentiating cells; and (b) the essential role of BRCA2 in replication/checkpoint is at least to prevent fork collapse into fatal injury rather than promote RAD51-mediated HR repair of collapsed forks.</p>
      <p>Consistently, in response to fork stalling, bacteria, budding or fission yeast do not undergo fork collapse; only replication/checkpoint mutants do, through the activities of HR enzymes (Branzei and Foiani <xref ref-type="bibr" rid="CR8">2005</xref>). Such organisms do not possess BRCA homologs and yet they carry out DSB repair almost exclusively by HR. In contrast, in organisms that possess BRCA homologs, NHEJ is the predominant DSB repair pathway, whether at collapsed forks or IR/enzyme-induced DSBs. Therefore, in such evolved organisms, one would expect NHEJ and SSA to rescue HR mutants from DSB-induced lethality. In contrast, KO of HR genes, such as <italic>RPA</italic>, <italic>RAD51</italic>, <italic>BRCA1</italic>, <italic>BARD1</italic>, <italic>MRE11</italic>, <italic>RAD50</italic>, <italic>NBS1</italic>, <italic>ATR</italic>, <italic>CHK1</italic>, <italic>RAD51</italic>B, <italic>RAD51</italic>D, <italic>XRCC</italic>2, <italic>TOP</italic>II, and <italic>BLM</italic>, in mice makes them all undergo chromosomal breakage and succumb to death in a manner similar to <italic>BRCA2</italic> KO mice (Friedberg and Meira <xref ref-type="bibr" rid="CR25">2006</xref>). Thus, in addition to their well-established role in HR repair of DSBs, RAD51 and its paralogs RAD51B, RAD51D and XRCCs are also essential for checkpoint/fork stability. Consistent with this aspect, not all RAD proteins required for HR repair of DSBs are essential for survival; <italic>RAD52</italic>, <italic>RAD54</italic> and <italic>RAD51</italic>C KO mice were all found to be viable (Friedberg and Meira <xref ref-type="bibr" rid="CR25">2006</xref>).</p>
      <p>In addition, ATM, master of the response to DSBs including their repair by HR, NHEJ and SSA, is also dispensable for survival; KO mice remain viable, except that they exhibit hyper-sensitivity to IR, gonadotrophy, infertility, immunodeficiency and thymic lymphoma, since in germ-line cells and lymphocytes, DSBs rather arise in a programmed manner to initiate meiotic HR, ensuring &#x201C;gene shuffling&#x201D; and the orderly segregation of homologous chromosomes and thus the formation of healthy gametes, and V(D)J recombination (NHEJ) for immune system development, protecting against infectious diseases and cancer (Friedberg and Meira <xref ref-type="bibr" rid="CR25">2006</xref>). In the absence of ATM, such &#x2018;heavenly&#x2019; breaks could trigger apoptosis/senescence and act as anti-cancer barriers in &#x2018;specialized&#x2019; tissues at the expense of their atrophy. Consistently, <italic>ATM</italic>/<italic>RAG1</italic> and <italic>ATM</italic>/<italic>RAG2</italic> double KO (DKO) mice that no longer undergo programmed DSBs and V(D)J recombination also develop CIN and lymphoma (Petiniot et al. <xref ref-type="bibr" rid="CR51">2002</xref>). Moreover, other ATM downstream targets that play a role in HR repair of DSBs are also dispensable for survival; <italic>CHK2</italic> and <italic>H2AX</italic> KO mice are as viable as <italic>ATM</italic>/<italic>CHK2</italic> and <italic>ATM</italic>/<italic>H2AX</italic> DKO mice (Friedberg and Meira <xref ref-type="bibr" rid="CR25">2006</xref>). Furthermore, NHEJ key components, including DNA-PK, another master of DSBs, Ku70, Ku80, Ku86 and Artemis, except ligase IV, are also dispensable for survival; KO mice remain viable (Friedberg and Meira <xref ref-type="bibr" rid="CR25">2006</xref>); and last but not least, genes of mutation-avoidance systems, such as base-excision repair/single-strand break repair (BER/SSBR) of oxidative damage (<italic>XRCC1</italic>, <italic>APEX</italic>, <italic>LIG</italic>1, <italic>POL</italic>&#x3B2;, <italic>FEN</italic>, <italic>PARP1</italic>/<italic>PARP2</italic>), nucleotide-excision repair (NER) and transcription-coupled NER of DNA adducts (<italic>XPD</italic>, <italic>XAB</italic>), or translesion DNA synthesis (TLS) (<italic>REV3</italic>), which are not necessary for DSB repair, all appear to be essential for survival (Friedberg and Meira <xref ref-type="bibr" rid="CR25">2006</xref>). Collectively, these findings indicate that (a) checkpoint/fork stability requires the participation of components of all DNA-damage repair mechanisms&#x2014;HR, SSA, NHEJ, BER/SSBR, NER and TLS&#x2014;rather than DNA damage/repair per se; (b) the same machinery that responds to programmed DSBs also acts to suppress accidental breakage in both specialized and normal tissues; and (c) DSB has been conceived as a fundamental requirement of life, evolution and death, acting as a &#x2018;longevity clock&#x2019; and &#x2018;quality control&#x2019;, eliminating aberrant proliferating/differentiating cells (cancer) and embryos (abortion).</p>
      <p>In such replication/checkpoint mutants, the collapse of stalled forks into lethal DSBs has been associated with cleavage of HR intermediates (HJs) resembling a chicken-foot structure that forms as a consequence of &#x201C;replication-fork reversal&#x201D; (RFR) or &#x201C;run-off&#x201D; of specialized SC junctions resembling hemicatenanes (pseudo-double HJs) (Branzei and Foiani <xref ref-type="bibr" rid="CR8">2005</xref>; Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). In yeast, pseudo-double HJs have been shown to form during the early S phase, after origin firing, and to migrate, chasing the forks and presumably assisting SCC/alignment until anaphase whereas in human cells, such SC bridges have been reported to form at fragile sites, after replication stress, and at anaphase before their resolution by BLM/TOPIII&#x3B1; and TOPII and SC segregation as two intact chromosomes (Branzei and Foiani <xref ref-type="bibr" rid="CR8">2005</xref>, <xref ref-type="bibr" rid="CR9">2007</xref>; Chan et al. <xref ref-type="bibr" rid="CR11">2007</xref>, <xref ref-type="bibr" rid="CR12">2009</xref>). In yeast, pseudo-double HJs are thought to form at stalled forks by strand invasion and D-loop formation (template switch) as an error-free DNA-damage bypass mechanism compared to TLS polymerases, which often replicate across lesions in an error-prone manner (Branzei and Foiani <xref ref-type="bibr" rid="CR9">2007</xref>). Since BRCA2<sup>&#x394;ex27</sup> cannot carry out RAD51-mediated strand invasion (Thorslund and West <xref ref-type="bibr" rid="CR60">2007</xref>), &#x2018;hemicatenation&#x2019; (HR) in mammals may result instead from BRCA2/RAD51-mediated strand switching: twisting/melting dsDNA into ssDNA and, thus, displacement of both lagging and leading strands and their subsequent annealing into one harmless DSB end, flipping out the chicken foot, recruiting/activating ATR, ATM and DNA-PK to terminate HR within an intact chromosome (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>A model for the BRCA2/RAD51 pathway in the response to stalled forks. After their recruitment by BRCA1/MRN, BRCA2/RAD51 complexes may act in concert to (i) disassemble chromatin (<italic>A</italic>); (ii) maintain SCC/alignment (<italic>B</italic>); (iii) effectuate strand-switching and thereby recruit/activate ATR to enhance SCC/alignment (<italic>C</italic>); (iv) provide one DSB end, and thereby activate ATM and DNA-PK (<italic>D</italic>); and (v) twist the DSB end after its processing at least by error-free TLS polymerases into leading and lagging strands that would anneal back with the original templates, and thereby yield a hemicatenane (<italic>E</italic>). If needed, the harmless DSB end (<italic>D</italic> and <italic>F</italic>) may engage in HR, NHEJ or SSA between neighbouring stalled forks during termination of the replication (S) phase (not shown). By interfering with ATR recruitment/activation, short EMSY could induce RFR (RAD51-independent HR) and chicken-foot formation (<italic>F</italic>). HJ-resolving enzymes against crossover, such as BLM and WRN, may prevent fork collapse (<italic>G</italic>) by competing with HJ-nicking enzymes (<italic>red arrows</italic>) at the expense of CIN. Unlike hyper-recombination, BRCA2/RAD51-mediated strand switching at either stalled forks (hemicatenation/RFR) or DSBs does not require RAD51-filament formation, in which case the fourfold decrease in HR repair of I-<italic>Sce</italic>I-induced DSBs by short EMSY could be attributed to apoptosis/senescence rather than decreased efficiency of strand switching. Consistently, meiotic HR does not require the loading of RAD51 oligomers by BRCA2 at programmed DSBs, since BRCA2<sup>&#x2206;ex27</sup> KO mice are as fertile as wild-type animals, except that they exhibit hypersensitivity to IR, senescence and reduced life span. Thus, whereas BRCA2/RAD51-mediated strand switching ensures survival, maintains chromosomal stability and acts as an anti-cancer barrier, SCRS and RAD51-mediated strand exchange/invasion can compete with RFR for ssDNA and thereby decrease the likelihood of forks collapse at the expense of CIN and human diseases. Only abnormally proliferating cells crippled in an essential gene are prone to gene mutation/reversion and fork collapse</p></caption><graphic xlink:href="438_2011_612_Fig5_HTML" id="MO5"/></fig></p>
      <p>In support of this, (a) its mini-homologs Brh2 and CeBRC2 that each contains only one RAD51-binding BRC motif and one ssDNA-binding domain possess the ability to twist dsDNA into both D-loops and ssDNA and carry out SSA (Petalcorin et al. <xref ref-type="bibr" rid="CR50">2006</xref>; Mazloum et al. <xref ref-type="bibr" rid="CR45">2007</xref>; Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>b). BRCA2<sup>&#x394;ex27</sup> would be expected to conduct such reactions with higher efficiency, as it still possesses eight dsDNA- and ssDNA-binding motifs through its interaction with RAD51, given that RAD51 binds to ssDNA (5&#x2032; or 3&#x2032;) and dsDNA with comparable affinities (Forget and Kowalczykowski <xref ref-type="bibr" rid="CR24">2010</xref>). In addition, the binding of RAD51 oligomers to the homologous dsDNA partner inhibits DNA strand-exchange/invasion in vitro and can be modulated by BRC repeats (Forget and Kowalczykowski <xref ref-type="bibr" rid="CR24">2010</xref>). In this case, BRCA2/RAD51 complexes together with free RAD51 oligomers may also stabilize replication forks by holding SCs aligned, acting as bridges until activation of replication/checkpoint that would disrupt RAD51 oligomers into monomers and recruit bona fide cohesins (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). (b) Mouse embryonic stem (ES) cells expressing BRCA2<sup>&#x394;ex27</sup> exhibit heightened efficiency of SSA at I-<italic>Sce</italic>I-induced DSBs and hyper-sensitivity to IR, but maintain both G1/S and G2/M checkpoints and resistance to UV radiation as wt ES cells (Morimatsu et al. <xref ref-type="bibr" rid="CR47">1998</xref>; Jasin <xref ref-type="bibr" rid="CR36">2002</xref>; Gudmundsdottir and Ashworth <xref ref-type="bibr" rid="CR29">2006</xref>), indicating that BRCA2<sup>&#x394;ex27</sup> is still efficient in recruiting/activating at least ATR and DNA-damage repair by error-free TLS, NER, BER/SSBR, or mismatch repair (MMR) (Branzei and Foiani <xref ref-type="bibr" rid="CR10">2008</xref>). MMR key proteins are also components of BASC (Wang et al. <xref ref-type="bibr" rid="CR68">2000</xref>), and although dispensable for survival (Friedberg and Meira <xref ref-type="bibr" rid="CR25">2006</xref>), they have also been implicated in DDR and the processing of HR intermediates containing HJs or branched DNA in collaboration with NER proteins (Villemure et al. <xref ref-type="bibr" rid="CR62">2003</xref>). (c) NER, transcription-coupled NER and PCNA-dependent pathways of BER/SSBR also require BRCA1, BRCA2, RPA, RAD51 and ATR (Le Page et al. <xref ref-type="bibr" rid="CR40">2000</xref>; Bogliolo et al. <xref ref-type="bibr" rid="CR7">2000</xref>; Daboussi et al. <xref ref-type="bibr" rid="CR19">2002</xref>; Aboussekhra and Al-Sharif <xref ref-type="bibr" rid="CR2">2005</xref>; Auclair et al. <xref ref-type="bibr" rid="CR5">2008</xref>). (d) As the localization of activated ATM and BRCA2/RAD51 complexes by BRCA1/MRN is needed for ATR activation in response to DSBs, that of ATR also seems to be required for ATM and DNA-PK activation in response to stalled forks (Stiff et al. <xref ref-type="bibr" rid="CR59">2006</xref>; Yajima et al. <xref ref-type="bibr" rid="CR74">2006</xref>). (e) BRCA1 and ATR have been shown to enforce TOPII-mediated decatenation G2 checkpoint (Deming et al. <xref ref-type="bibr" rid="CR20">2001</xref>). In normal proliferating cells, all replication forks would stall at termination of the S phase by catenanes, positive DNA supercoils that develop under torsional stress between advancing/colliding forks, acting as topological barriers, activating TOPII-mediated decatenation of SCs to allow completion of the S phase, chromosome condensation and segregation during the G2 and M phases (Deming et al. <xref ref-type="bibr" rid="CR20">2001</xref>; Branzei and Foiani <xref ref-type="bibr" rid="CR10">2008</xref>). Thus, with its HAT on doing the twist and changing partners at DNA, BRCA2<sup>&#x394;ex27</sup> still has the ability to provide a finger to any stalled fork, and thereby act upstream and downstream of PIKKs, orchestrating at least S/G2/M-transition checkpoints and mutation-avoidance systems as full-length BRCA2, ensuring the accuracy rather than efficiency of such DNA transactions that can be carried out in vitro and by organisms that do not possess BRCA homologs.</p>
      <p>In addition, unlike humans, <italic>BRCA2</italic><sup>&#x394;ex27</sup> KO mice or mice heterozygous for BRCA2-truncating mutations are not spontaneously more cancer-prone than wt animals (Donoho et al. <xref ref-type="bibr" rid="CR21">2003</xref>; Evers and Jonkers <xref ref-type="bibr" rid="CR23">2006</xref>). Moreover, unlike BRCA2-deficient human cells (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>), mouse cells expressing BRCA2<sup>&#x394;ex27</sup> have not been reported to undergo hyper-recombination or SCRS (Gudmundsdottir and Ashworth <xref ref-type="bibr" rid="CR29">2006</xref>; Moynahan and Jasin <xref ref-type="bibr" rid="CR48">2010</xref>). These two &#x2018;mutator&#x2019; phenotypes and cancer predisposition highlight the importance of both replication/checkpoint in chromosomal stability and the difference between human and mouse BRCA2. Whereas human BRCA2 contains one nuclear localization signal (NLS) at the C-terminal domain, mouse BRCA2 possesses an additional NLS at the N-terminal domain (Jasin <xref ref-type="bibr" rid="CR36">2002</xref>). The majority of inherited, cancer-eliciting BRCA2 mutations encode truncated proteins as in CAPAN-1 cells, where BRCA2 is truncated at exon 11, weakly expressed, and exclusively localized in the cytoplasm, allowing both hyper-recombination and SCRS to take place (Abaji et al. <xref ref-type="bibr" rid="CR1">2005</xref>). Conversely, truncated mouse BRCA2<sup>&#x394;ex27</sup> is expressed normally and localizes exclusively in the nucleus (Jasin <xref ref-type="bibr" rid="CR36">2002</xref>).</p>
      <p>Hyper-recombination and its hallmarks are characteristic features of not only <italic>BRCA</italic>-deficient and <italic>BRCA</italic>-haploinsufficient tumor cells, but also normal breast epithelial cells and lymphocytes from healthy carriers of <italic>BRCA</italic> mutations, indicating that a &#x2018;single hit&#x2019; in a chromosomal stability gene is sufficient to deregulate HR and induce CIN and the emergence of pre-cancerous lesions (Cousineau and Belmaaza <xref ref-type="bibr" rid="CR18">2007</xref>). Although somatic <italic>BRCA</italic> mutations are scarce in sporadic breast cancer, representing less than 1%, the remaining cases are either <italic>BRCA1</italic>- or <italic>BRCA2</italic>-haploinsufficient due to loss (deletion/aneuploidy) or epigenetic silencing of wt <italic>BRCA</italic> alleles (Welcsh and King <xref ref-type="bibr" rid="CR70">2001</xref>), and all exhibit amplification of oncogenes most notably <italic>EMSY</italic>, <italic>MYC</italic>, <italic>E2F-1</italic>, <italic>CyclinD1</italic>, or <italic>AKT</italic>, or loss of tumor-suppressor genes, such as <italic>PTEN</italic>, <italic>p53</italic>, or <italic>RB</italic> (Kenemans et al. <xref ref-type="bibr" rid="CR39">2004</xref>). Similar to <italic>EMSY</italic>, amplification/overexpression of other oncogenes, such as <italic>MYC</italic> or <italic>E2F-1</italic>, has also been shown to induce fork stalling and CIN as well as fork collapse into DSBs, activating ATM and not ATR, triggering apoptosis/senescence, acting as an anti-cancer barrier (Hong et al. <xref ref-type="bibr" rid="CR33">2006</xref>; Halazonetis et al. <xref ref-type="bibr" rid="CR30">2008</xref>). Thus, oncogenes can behave as tumor suppressors. Similarly, aneuploidy also acts both oncogenically and as a tumor suppressor (Weaver et al. <xref ref-type="bibr" rid="CR69">2007</xref>).</p>
      <p>Hyper-recombination and its hallmarks are also characteristic features of <italic>PARP1</italic>- and <italic>ATM</italic>-deficient cells or KO mice (Claybon et al. <xref ref-type="bibr" rid="CR15">2010</xref>) and cells disrupted in DNA-PK (Allen et al. <xref ref-type="bibr" rid="CR4">2002</xref>) or MMR proteins (Villemure et al. <xref ref-type="bibr" rid="CR62">2003</xref>), or cells expressing p53 mutant proteins (Daboussi et al. <xref ref-type="bibr" rid="CR19">2002</xref>; Akyuz et al. <xref ref-type="bibr" rid="CR3">2002</xref>; Lemelin et al. <xref ref-type="bibr" rid="CR41">2005</xref>) or derived from patients with CIN syndromes, such as ataxia telangiectasia, Bloom&#x2019;s syndrome, Werner&#x2019;s syndrome, and Fanconi&#x2019;s anemia, associated with mutations in <italic>ATM</italic>, <italic>BLM</italic>, <italic>WRN</italic>, and several <italic>FANC</italic> genes, respectively (Meyn <xref ref-type="bibr" rid="CR46">1997</xref>). Consistently, the most notable of <italic>FANC</italic> genes include <italic>FANC</italic>-D1 (<italic>BRCA2</italic>), <italic>FANC</italic>-D2, <italic>FANC</italic>-J (<italic>BRIP1</italic>, <italic>BACH1</italic>), and <italic>FANC</italic>-N (<italic>PALB2</italic>) (Walsh and King <xref ref-type="bibr" rid="CR66">2007</xref>). In addition, similar to <italic>BRCA1</italic> and <italic>BRCA2</italic>, the inheritance of a mutated copy of <italic>ATM</italic>, <italic>PALB2</italic>, <italic>BRIP1</italic>, <italic>p53</italic> or <italic>CHK2</italic> (mutated in Li-Fraumeni syndrome), <italic>MRE11</italic> (mutated in ataxia telangiectasia-like disease), <italic>NBS1</italic> (mutated in Nijmegen breakage syndrome), or <italic>PTEN</italic> (mutated in Cowden disease) also confers a high lifetime risk of developing breast cancer (Walsh and King <xref ref-type="bibr" rid="CR66">2007</xref>). Cancer predisposition aside, patients with these syndromes also suffer from several other illnesses, such as neurological and cardiovascular diseases, diabetes, immunodeficiency, anemia, infertility, or premature aging as patients with Xeroderma pigmentosum, Cockyane syndrome, Trichothiodystrophy and Rothmund-Thompson syndrome, associated with mutations in components of NER, transcription-coupled NER, and RecQ-like DNA helicases such as BLM and WRN (Shiloh <xref ref-type="bibr" rid="CR55">2003</xref>; Vogelstein and Kinzler <xref ref-type="bibr" rid="CR65">2004</xref>; Branzei and Foiani <xref ref-type="bibr" rid="CR10">2008</xref>).</p>
      <p>In conclusion, we briefly wielded the &#x2018;triple-edged&#x2019; sword of HR: life, death and human diseases. That BRCA1 and BRCA2 act upstream of PIKKs as the masters of chromosomal stability may also explain: (a) why among all the inherited, breast cancer-eliciting gene mutations identified to date, <italic>BRCA1</italic> and <italic>BRCA2</italic> represent the majority of cases, whereas <italic>ATM</italic>, <italic>CHK2</italic>, p<italic>53</italic>, <italic>MRE11</italic>, <italic>RAD50</italic>, <italic>PALB2</italic>, <italic>BRIP1</italic> (<italic>BACH1</italic>) and <italic>PTEN</italic> each accounts for approximately 1% of the remaining cases (Walsh and King <xref ref-type="bibr" rid="CR66">2007</xref>); (b) why in sporadic breast cancer, the majority if not all cases are either <italic>BRCA1</italic>- or <italic>BRCA2</italic>-haploinsufficient (Welcsh and King <xref ref-type="bibr" rid="CR70">2001</xref>); and (c) why breast cancer exhibits decreased or increased levels of almost exclusively those proteins that interact with BRCA1 and BRCA2. This indicates that (a) cancer may be a gene-dosage disease, in which tumor-suppressor genes and oncogenes are two facets of the same process with dosage amount acting both as a cancer promoter and an anti-cancer barrier through fork stalling and collapse, respectively; and (b) tissue specificity of the tumor-suppressive or -promoting property of all these housekeeping chromosomal stability genes may be determined by tissue-specific DNA-damaging agents, such as estrogens, anti-estrogens and phytoestrogens in breast cancer. The anti-cancer facet of such compounds could be enhanced if employed as tissue-specific carriers of potent DSB-inducing drugs.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We are grateful to Dr. Luke Hughes-Davies (Cancer Research UK/Wellcome Trust Institute and the Departments of Pathology and Oncology, University of Cambridge, UK) for generously providing us with pcDNA-EMSY and EMSY antisera. We also thank Mr. Ovid Da Silva and the Research Support Office, CRCHUM, for his editorial assistance. This work was supported by the following grants: Canadian Institutes of Health Research/Canadian Breast Cancer Research Alliance (A. Belmaaza), and a Canderel fellowship and bursary from Facult&#xE9; des &#xE9;tudes sup&#xE9;rieures, Universit&#xE9; de Montr&#xE9;al, and Institut du Cancer de Montr&#xE9;al (I. Cousineau).</p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abaji</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cousineau</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Belmaaza</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>BRCA2 regulates homologous recombination in response to DNA damage: implications for genome stability and carcinogenesis</article-title>
          <source>Cancer Res</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>4117</fpage>
          <lpage>4125</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-3071</pub-id>
          <pub-id pub-id-type="pmid">15899802</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aboussekhra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Al-Sharif</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>Homologous recombination is involved in transcription-coupled repair of UV damage in <italic>Saccharomyces cerevisiae</italic></article-title>
          <source>EMBO J</source>
          <year>2005</year>
          <volume>24</volume>
          <fpage>1999</fpage>
          <lpage>2010</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.emboj.7600665</pub-id>
          <pub-id pub-id-type="pmid">15902273</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akyuz</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Boehden</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Susse</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rimek</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Preuss</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Scheidtmann</surname>
              <given-names>KH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DNA substrate dependence of p53-mediated regulation of double-strand break repair</article-title>
          <source>Mol Cell Biol</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>6306</fpage>
          <lpage>6317</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.22.17.6306-6317.2002</pub-id>
          <pub-id pub-id-type="pmid">12167722</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kurimasa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brenneman</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Nickoloff</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>DNA-dependent protein kinase suppresses double-strand break-induced and spontaneous homologous recombination</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>3758</fpage>
          <lpage>3763</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.052545899</pub-id>
          <pub-id pub-id-type="pmid">11904432</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Auclair</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Rouget</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Affarel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Drobetsky</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>ATR kinase is required for global genomic nucleotide excision repair exclusively during S phase in human cells</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2008</year>
          <volume>105</volume>
          <fpage>17896</fpage>
          <lpage>17901</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0801585105</pub-id>
          <pub-id pub-id-type="pmid">19004803</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belmaaza</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chartrand</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>One-sided invasion events in homologous recombination at double-strand breaks</article-title>
          <source>Mutat Res</source>
          <year>1994</year>
          <volume>314</volume>
          <fpage>199</fpage>
          <lpage>208</lpage>
          <pub-id pub-id-type="pmid">7513053</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bogliolo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Caldecott</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Frosina</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Reduced ligation during DNA base excision repair supported by BRCA2 mutant cells</article-title>
          <source>Oncogene</source>
          <year>2000</year>
          <volume>19</volume>
          <fpage>5781</fpage>
          <lpage>5787</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1203951</pub-id>
          <pub-id pub-id-type="pmid">11126365</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR8">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Branzei</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Foiani</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The DNA damage response during DNA replication</article-title>
          <source>Curr Opin Cell Biol</source>
          <year>2005</year>
          <volume>17</volume>
          <fpage>568</fpage>
          <lpage>575</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ceb.2005.09.003</pub-id>
          <pub-id pub-id-type="pmid">16226452</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR9">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Branzei</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Foiani</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Interplay of replication checkpoints and repair proteins at stalled replication forks</article-title>
          <source>DNA Repair (Amst)</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>994</fpage>
          <lpage>1003</lpage>
          <pub-id pub-id-type="doi">10.1016/j.dnarep.2007.02.018</pub-id>
          <pub-id pub-id-type="pmid">17382606</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR10">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Branzei</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Foiani</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Regulation of DNA repair throughout the cell cycle</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2008</year>
          <volume>9</volume>
          <fpage>297</fpage>
          <lpage>308</lpage>
          <pub-id pub-id-type="doi">10.1038/nrm2351</pub-id>
          <pub-id pub-id-type="pmid">18285803</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR11">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>North</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>ID</given-names>
            </name>
          </person-group>
          <article-title>BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges</article-title>
          <source>EMBO J</source>
          <year>2007</year>
          <volume>26</volume>
          <fpage>3397</fpage>
          <lpage>3409</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.emboj.7601777</pub-id>
          <pub-id pub-id-type="pmid">17599064</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR12">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Palmai-Pallag</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ying</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>ID</given-names>
            </name>
          </person-group>
          <article-title>Replication stress induces sister-chromatid bridging at fragile site loci in mitosis</article-title>
          <source>Nat Cell Biol</source>
          <year>2009</year>
          <volume>11</volume>
          <fpage>753</fpage>
          <lpage>760</lpage>
          <pub-id pub-id-type="doi">10.1038/ncb1882</pub-id>
          <pub-id pub-id-type="pmid">19465922</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR13">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Koritzinsky</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bindra</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Glazer</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Powell</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance</article-title>
          <source>Cancer Res</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>605</fpage>
          <lpage>614</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-5472</pub-id>
          <pub-id pub-id-type="pmid">18199558</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR14">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nievera</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair</article-title>
          <source>J Biol Chem</source>
          <year>2008</year>
          <volume>283</volume>
          <fpage>7713</fpage>
          <lpage>7720</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M710245200</pub-id>
          <pub-id pub-id-type="pmid">18171670</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR15">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Claybon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Karia</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bruce</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bishop</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>PARP1 suppresses homologous recombination events in mice in vivo</article-title>
          <source>Nucleic Acids Res</source>
          <year>2010</year>
          <volume>38</volume>
          <fpage>7538</fpage>
          <lpage>7545</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkq624</pub-id>
          <pub-id pub-id-type="pmid">20660013</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR16">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conilleau</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takizawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tachiwana</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fleury</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kurumizaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Location of tyrosine 315, a target for phosphorylation by cAbl tyrosine kinase, at the edge of the subunit-subunit interface of the human Rad51 filament</article-title>
          <source>J Mol Biol</source>
          <year>2004</year>
          <volume>339</volume>
          <fpage>797</fpage>
          <lpage>804</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmb.2004.04.017</pub-id>
          <pub-id pub-id-type="pmid">15165851</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR17">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cousineau</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Abaji</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Belmaaza</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis</article-title>
          <source>Cancer Res</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>11384</fpage>
          <lpage>11391</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-2156</pub-id>
          <pub-id pub-id-type="pmid">16357146</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR18">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cousineau</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Belmaaza</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>BRCA1 haploinsufficiency, but not heterozygosity for a BRCA1-truncating mutation, deregulates homologous recombination</article-title>
          <source>Cell Cycle</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>962</fpage>
          <lpage>971</lpage>
          <pub-id pub-id-type="doi">10.4161/cc.6.8.4105</pub-id>
          <pub-id pub-id-type="pmid">17404506</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR19">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daboussi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dumay</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Delacote</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>BS</given-names>
            </name>
          </person-group>
          <article-title>DNA double-strand break repair signalling: the case of RAD51 post-translational regulation</article-title>
          <source>Cell Signal</source>
          <year>2002</year>
          <volume>14</volume>
          <fpage>969</fpage>
          <lpage>975</lpage>
          <pub-id pub-id-type="doi">10.1016/S0898-6568(02)00052-9</pub-id>
          <pub-id pub-id-type="pmid">12359302</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR20">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deming</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Cistulli</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Graves</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Piwnica-Worms</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Paules</surname>
              <given-names>RS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The human decatenation checkpoint</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2001</year>
          <volume>98</volume>
          <fpage>12044</fpage>
          <lpage>12049</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.221430898</pub-id>
          <pub-id pub-id-type="pmid">11593014</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR21">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donoho</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Brenneman</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>TX</given-names>
            </name>
            <name>
              <surname>Donoviel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Goodwin</surname>
              <given-names>EH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>2003</year>
          <volume>36</volume>
          <fpage>317</fpage>
          <lpage>331</lpage>
          <pub-id pub-id-type="doi">10.1002/gcc.10148</pub-id>
          <pub-id pub-id-type="pmid">12619154</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR22">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eszterhas</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Bouhassira</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Fiering</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Transcriptional interference by independently regulated genes occurs in any relative arrangement of the genes and is influenced by chromosomal integration position</article-title>
          <source>Mol Cell Biol</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>469</fpage>
          <lpage>479</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.22.2.469-479.2002</pub-id>
          <pub-id pub-id-type="pmid">11756543</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR23">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evers</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Jonkers</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects</article-title>
          <source>Oncogene</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>5885</fpage>
          <lpage>5897</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1209871</pub-id>
          <pub-id pub-id-type="pmid">16998503</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR24">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forget</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Kowalczykowski</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Single-molecule imaging brings Rad51 nucleoprotein filaments into focus</article-title>
          <source>Trends Cell Biol</source>
          <year>2010</year>
          <volume>20</volume>
          <fpage>269</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tcb.2010.02.004</pub-id>
          <pub-id pub-id-type="pmid">20299221</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR25">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedberg</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Meira</surname>
              <given-names>LB</given-names>
            </name>
          </person-group>
          <article-title>Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage Version 7</article-title>
          <source>DNA Repair (Amst)</source>
          <year>2006</year>
          <volume>5</volume>
          <fpage>189</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="doi">10.1016/j.dnarep.2005.09.009</pub-id>
          <pub-id pub-id-type="pmid">16290067</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR26">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Golding</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Khalil</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>McEwen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Neill</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>15402</fpage>
          <lpage>15410</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M314191200</pub-id>
          <pub-id pub-id-type="pmid">14744854</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR27">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greenberg</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Sobhian</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pathania</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cantor</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Nakatani</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Livingston</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes</article-title>
          <source>Genes Dev</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>34</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="doi">10.1101/gad.1381306</pub-id>
          <pub-id pub-id-type="pmid">16391231</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR28">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Groth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Verreault</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Almouzni</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Chromatin challenges during DNA replication and repair</article-title>
          <source>Cell</source>
          <year>2007</year>
          <volume>128</volume>
          <fpage>721</fpage>
          <lpage>733</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2007.01.030</pub-id>
          <pub-id pub-id-type="pmid">17320509</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR29">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gudmundsdottir</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ashworth</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability</article-title>
          <source>Oncogene</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>5864</fpage>
          <lpage>5874</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1209874</pub-id>
          <pub-id pub-id-type="pmid">16998501</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR30">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halazonetis</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Gorgoulis</surname>
              <given-names>VG</given-names>
            </name>
            <name>
              <surname>Bartek</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>An oncogene-induced DNA damage model for cancer development</article-title>
          <source>Science</source>
          <year>2008</year>
          <volume>319</volume>
          <fpage>1352</fpage>
          <lpage>1355</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1140735</pub-id>
          <pub-id pub-id-type="pmid">18323444</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR31">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harper</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Elledge</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>The DNA damage response: ten years after</article-title>
          <source>Mol Cell</source>
          <year>2007</year>
          <volume>28</volume>
          <fpage>739</fpage>
          <lpage>745</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2007.11.015</pub-id>
          <pub-id pub-id-type="pmid">18082599</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR32">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henikoff</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Conspiracy of silence among repeated transgenes</article-title>
          <source>Bioessays</source>
          <year>1998</year>
          <volume>20</volume>
          <fpage>532</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1521-1878(199807)20:7&lt;532::AID-BIES3&gt;3.0.CO;2-M</pub-id>
          <pub-id pub-id-type="pmid">9723001</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR33">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hong</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pusapati</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Powers</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis</article-title>
          <source>Cell Cycle</source>
          <year>2006</year>
          <volume>5</volume>
          <fpage>801</fpage>
          <lpage>803</lpage>
          <pub-id pub-id-type="doi">10.4161/cc.5.8.2638</pub-id>
          <pub-id pub-id-type="pmid">16582589</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR34">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hughes-Davies</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Huntsman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ruas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fuks</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bye</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chin</surname>
              <given-names>SF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer</article-title>
          <source>Cell</source>
          <year>2003</year>
          <volume>115</volume>
          <fpage>523</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(03)00930-9</pub-id>
          <pub-id pub-id-type="pmid">14651845</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR35">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Igoucheva</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Alexeev</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Differential cellular responses to exogenous DNA in mammalian cells and its effect on oligonucleotide-directed gene modification</article-title>
          <source>Gene Ther</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>266</fpage>
          <lpage>275</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.gt.3302643</pub-id>
          <pub-id pub-id-type="pmid">16177821</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR36">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jasin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Homologous repair of DNA damage and tumorigenesis: the BRCA connection</article-title>
          <source>Oncogene</source>
          <year>2002</year>
          <volume>21</volume>
          <fpage>8981</fpage>
          <lpage>8993</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1206176</pub-id>
          <pub-id pub-id-type="pmid">12483514</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR37">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jazayeri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Falck</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lukas</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bartek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Lukas</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks</article-title>
          <source>Nat Cell Biol</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>37</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1038/ncb1337</pub-id>
          <pub-id pub-id-type="pmid">16327781</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR38">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kastan</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Bartek</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Cell-cycle checkpoints and cancer</article-title>
          <source>Nature</source>
          <year>2004</year>
          <volume>432</volume>
          <fpage>316</fpage>
          <lpage>323</lpage>
          <pub-id pub-id-type="doi">10.1038/nature03097</pub-id>
          <pub-id pub-id-type="pmid">15549093</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR39">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kenemans</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Verstraeten</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Verheijen</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Oncogenic pathways in hereditary and sporadic breast cancer</article-title>
          <source>Maturitas</source>
          <year>2004</year>
          <volume>49</volume>
          <fpage>34</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.1016/j.maturitas.2004.06.005</pub-id>
          <pub-id pub-id-type="pmid">15351094</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR40">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Le Page</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Randrianarison</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Marot</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cabannes</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Perricaudet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Feunteun</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells</article-title>
          <source>Cancer Res</source>
          <year>2000</year>
          <volume>60</volume>
          <fpage>5548</fpage>
          <lpage>5552</lpage>
          <pub-id pub-id-type="pmid">11034101</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR41">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lemelin</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Abaji</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cousineau</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Belmaaza</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Disruption of p53 by the viral oncoprotein HPV16-E6 does not deregulate chromosomal homologous recombination in a transcriptional interference-free assay system</article-title>
          <source>Cell Cycle</source>
          <year>2005</year>
          <volume>4</volume>
          <fpage>831</fpage>
          <lpage>837</lpage>
          <pub-id pub-id-type="doi">10.4161/cc.4.6.1725</pub-id>
          <pub-id pub-id-type="pmid">15908792</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR42">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Litman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Powell</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ</article-title>
          <source>Cancer Cell</source>
          <year>2005</year>
          <volume>8</volume>
          <fpage>255</fpage>
          <lpage>265</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ccr.2005.08.004</pub-id>
          <pub-id pub-id-type="pmid">16153896</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR43">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lomonosov</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Anand</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sangrithi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Venkitaraman</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein</article-title>
          <source>Genes Dev</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>3017</fpage>
          <lpage>3022</lpage>
          <pub-id pub-id-type="doi">10.1101/gad.279003</pub-id>
          <pub-id pub-id-type="pmid">14681210</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR44">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marmorstein</surname>
              <given-names>LY</given-names>
            </name>
            <name>
              <surname>Ouchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Aaronson</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>The BRCA2 gene product functionally interacts with p53 and RAD51</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>13869</fpage>
          <lpage>13874</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.95.23.13869</pub-id>
          <pub-id pub-id-type="pmid">9811893</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR45">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mazloum</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Holloman</surname>
              <given-names>WK</given-names>
            </name>
          </person-group>
          <article-title>DNA binding, annealing, and strand exchange activities of Brh2 protein from Ustilago maydis</article-title>
          <source>Biochemistry</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>7163</fpage>
          <lpage>7173</lpage>
          <pub-id pub-id-type="doi">10.1021/bi700399m</pub-id>
          <pub-id pub-id-type="pmid">17523678</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR46">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyn</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Chromosome instability syndromes: lessons for carcinogenesis</article-title>
          <source>Curr Top Microbiol Immunol</source>
          <year>1997</year>
          <volume>221</volume>
          <fpage>71</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="pmid">8979441</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR47">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morimatsu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Donoho</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hasty</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence</article-title>
          <source>Cancer Res</source>
          <year>1998</year>
          <volume>58</volume>
          <fpage>3441</fpage>
          <lpage>3447</lpage>
          <pub-id pub-id-type="pmid">9699678</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR48">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moynahan</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Jasin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>196</fpage>
          <lpage>207</lpage>
          <pub-id pub-id-type="doi">10.1038/nrm2851</pub-id>
          <pub-id pub-id-type="pmid">20177395</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR49">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nievera</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>The Mre11 complex mediates the S-phase checkpoint through an interaction with replication protein A</article-title>
          <source>Mol Cell Biol</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>6053</fpage>
          <lpage>6067</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.00532-07</pub-id>
          <pub-id pub-id-type="pmid">17591703</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR50">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petalcorin</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Sandall</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wigley</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Boulton</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>CeBRC-2 stimulates D-loop formation by RAD-51 and promotes DNA single-strand annealing</article-title>
          <source>J Mol Biol</source>
          <year>2006</year>
          <volume>361</volume>
          <fpage>231</fpage>
          <lpage>242</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmb.2006.06.020</pub-id>
          <pub-id pub-id-type="pmid">16843491</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR51">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petiniot</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Vacchio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wangsa</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice</article-title>
          <source>Mol Cell Biol</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>3174</fpage>
          <lpage>3177</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.22.9.3174-3177.2002</pub-id>
          <pub-id pub-id-type="pmid">11940674</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR52">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raouf</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vrcelj</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>To</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kwok</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Huntsman</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY</article-title>
          <source>J Natl Cancer Inst</source>
          <year>2005</year>
          <volume>97</volume>
          <fpage>1302</fpage>
          <lpage>1306</lpage>
          <pub-id pub-id-type="doi">10.1093/jnci/dji254</pub-id>
          <pub-id pub-id-type="pmid">16145051</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR53">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scully</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Livingston</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>In search of the tumour-suppressor functions of BRCA1 and BRCA2</article-title>
          <source>Nature</source>
          <year>2000</year>
          <volume>408</volume>
          <fpage>429</fpage>
          <lpage>432</lpage>
          <pub-id pub-id-type="doi">10.1038/35044000</pub-id>
          <pub-id pub-id-type="pmid">11100717</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR54">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Balajee</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Eng</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pandolfi</surname>
              <given-names>PP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Essential role for nuclear PTEN in maintaining chromosomal integrity</article-title>
          <source>Cell</source>
          <year>2007</year>
          <volume>128</volume>
          <fpage>157</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2006.11.042</pub-id>
          <pub-id pub-id-type="pmid">17218262</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR55">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shiloh</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>ATM and related protein kinases: safeguarding genome integrity</article-title>
          <source>Nat Rev Cancer</source>
          <year>2003</year>
          <volume>3</volume>
          <fpage>155</fpage>
          <lpage>168</lpage>
          <pub-id pub-id-type="doi">10.1038/nrc1011</pub-id>
          <pub-id pub-id-type="pmid">12612651</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR56">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sleeth</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Sorensen</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Issaeva</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Dziegielewski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bartek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Helleday</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>RPA mediates recombination repair during replication stress and is displaced from DNA by checkpoint signalling in human cells</article-title>
          <source>J Mol Biol</source>
          <year>2007</year>
          <volume>373</volume>
          <fpage>38</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmb.2007.07.068</pub-id>
          <pub-id pub-id-type="pmid">17765923</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR57">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sorensen</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Dziegielewski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Syljuasen</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Lundin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bartek</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair</article-title>
          <source>Nat Cell Biol</source>
          <year>2005</year>
          <volume>7</volume>
          <fpage>195</fpage>
          <lpage>201</lpage>
          <pub-id pub-id-type="doi">10.1038/ncb1212</pub-id>
          <pub-id pub-id-type="pmid">15665856</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR58">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stauffer</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Chazin</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>Physical interaction between replication protein A and Rad51 promotes exchange on single-stranded DNA</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>25638</fpage>
          <lpage>25645</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M400029200</pub-id>
          <pub-id pub-id-type="pmid">15056657</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR59">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stiff</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Cerosaletti</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Goodarzi</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Petermann</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Concannon</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling</article-title>
          <source>EMBO J</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>5775</fpage>
          <lpage>5782</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.emboj.7601446</pub-id>
          <pub-id pub-id-type="pmid">17124492</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR60">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thorslund</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>BRCA2: a universal recombinase regulator</article-title>
          <source>Oncogene</source>
          <year>2007</year>
          <volume>26</volume>
          <fpage>7720</fpage>
          <lpage>7730</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1210870</pub-id>
          <pub-id pub-id-type="pmid">18066084</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR61">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Venkitaraman</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Cancer susceptibility and the functions of BRCA1 and BRCA2</article-title>
          <source>Cell</source>
          <year>2002</year>
          <volume>108</volume>
          <fpage>171</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(02)00615-3</pub-id>
          <pub-id pub-id-type="pmid">11832208</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR62">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Villemure</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Abaji</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cousineau</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Belmaaza</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>MSH2-deficient human cells exhibit a defect in the accurate termination of homology-directed repair of DNA double-strand breaks</article-title>
          <source>Cancer Res</source>
          <year>2003</year>
          <volume>63</volume>
          <fpage>3334</fpage>
          <lpage>3339</lpage>
          <pub-id pub-id-type="pmid">12810667</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR63">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Villemure</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Belmaaza</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chartrand</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The processing of DNA ends at double-strand breaks during homologous recombination: different roles for the two ends</article-title>
          <source>Mol Gen Genet</source>
          <year>1997</year>
          <volume>256</volume>
          <fpage>533</fpage>
          <lpage>538</lpage>
          <pub-id pub-id-type="doi">10.1007/s004380050598</pub-id>
          <pub-id pub-id-type="pmid">9413437</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR64">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Villemure</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Savard</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Belmaaza</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Promoter suppression in cultured mammalian cells can be blocked by the chicken beta-globin chromatin insulator 5&#x2032;HS4 and matrix/scaffold attachment regions</article-title>
          <source>J Mol Biol</source>
          <year>2001</year>
          <volume>312</volume>
          <fpage>963</fpage>
          <lpage>974</lpage>
          <pub-id pub-id-type="doi">10.1006/jmbi.2001.5015</pub-id>
          <pub-id pub-id-type="pmid">11580242</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR65">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vogelstein</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kinzler</surname>
              <given-names>KW</given-names>
            </name>
          </person-group>
          <article-title>Cancer genes and the pathways they control</article-title>
          <source>Nat Med</source>
          <year>2004</year>
          <volume>10</volume>
          <fpage>789</fpage>
          <lpage>799</lpage>
          <pub-id pub-id-type="doi">10.1038/nm1087</pub-id>
          <pub-id pub-id-type="pmid">15286780</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR66">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walsh</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Ten genes for inherited breast cancer</article-title>
          <source>Cancer Cell</source>
          <year>2007</year>
          <volume>11</volume>
          <fpage>103</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ccr.2007.01.010</pub-id>
          <pub-id pub-id-type="pmid">17292821</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR67">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Powell</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Iliakis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>ATR affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joining</article-title>
          <source>Cancer Res</source>
          <year>2004</year>
          <volume>64</volume>
          <fpage>7139</fpage>
          <lpage>7143</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-1289</pub-id>
          <pub-id pub-id-type="pmid">15466211</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR68">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Cortez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Yazdi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Neff</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Elledge</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures</article-title>
          <source>Genes Dev</source>
          <year>2000</year>
          <volume>14</volume>
          <fpage>927</fpage>
          <lpage>939</lpage>
          <pub-id pub-id-type="pmid">10783165</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR69">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weaver</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Silk</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Montagna</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Verdier-Pinard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cleveland</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Aneuploidy acts both oncogenically and as a tumor suppressor</article-title>
          <source>Cancer Cell</source>
          <year>2007</year>
          <volume>11</volume>
          <fpage>25</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ccr.2006.12.003</pub-id>
          <pub-id pub-id-type="pmid">17189716</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR70">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Welcsh</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>BRCA1 and BRCA2 and the genetics of breast and ovarian cancer</article-title>
          <source>Hum Mol Genet</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>705</fpage>
          <lpage>713</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/10.7.705</pub-id>
          <pub-id pub-id-type="pmid">11257103</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR71">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Westermark</surname>
              <given-names>UK</given-names>
            </name>
            <name>
              <surname>Reyngold</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Olshen</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Baer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jasin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moynahan</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks</article-title>
          <source>Mol Cell Biol</source>
          <year>2003</year>
          <volume>23</volume>
          <fpage>7926</fpage>
          <lpage>7936</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.23.21.7926-7936.2003</pub-id>
          <pub-id pub-id-type="pmid">14560035</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR72">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ionescu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ingles</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Interaction between BRCA2 and replication protein A is compromised by a cancer-predisposing mutation in BRCA2</article-title>
          <source>Oncogene</source>
          <year>2003</year>
          <volume>22</volume>
          <fpage>28</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1206071</pub-id>
          <pub-id pub-id-type="pmid">12527904</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR73">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xia</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sheng</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Nakanishi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohashi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Christ</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2</article-title>
          <source>Mol Cell</source>
          <year>2006</year>
          <volume>22</volume>
          <fpage>719</fpage>
          <lpage>729</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2006.05.022</pub-id>
          <pub-id pub-id-type="pmid">16793542</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR74">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yajima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>BP</given-names>
            </name>
          </person-group>
          <article-title>ATR-dependent phosphorylation of DNA-dependent protein kinase catalytic subunit in response to UV-induced replication stress</article-title>
          <source>Mol Cell Biol</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>7520</fpage>
          <lpage>7528</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.00048-06</pub-id>
          <pub-id pub-id-type="pmid">16908529</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR75">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>YG</given-names>
            </name>
            <name>
              <surname>Saidi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Frappart</surname>
              <given-names>PO</given-names>
            </name>
            <name>
              <surname>Min</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Barrucand</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dumon-Jones</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Conditional deletion of Nbs1 in murine cells reveals its role in branching repair pathways of DNA double-strand breaks</article-title>
          <source>EMBO J</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>5527</fpage>
          <lpage>5538</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.emboj.7601411</pub-id>
          <pub-id pub-id-type="pmid">17082765</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR76">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ye</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>Defective S phase chromatin assembly causes DNA damage, activation of the S phase checkpoint, and S phase arrest</article-title>
          <source>Mol Cell</source>
          <year>2003</year>
          <volume>11</volume>
          <fpage>341</fpage>
          <lpage>351</lpage>
          <pub-id pub-id-type="doi">10.1016/S1097-2765(03)00037-6</pub-id>
          <pub-id pub-id-type="pmid">12620223</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR77">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Sonoda</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Pellegrini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Blundell</surname>
              <given-names>TL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dynamic control of Rad51 recombinase by self-association and interaction with BRCA2</article-title>
          <source>Mol Cell</source>
          <year>2003</year>
          <volume>12</volume>
          <fpage>1029</fpage>
          <lpage>1041</lpage>
          <pub-id pub-id-type="doi">10.1016/S1097-2765(03)00394-0</pub-id>
          <pub-id pub-id-type="pmid">14580352</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR78">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yuan</surname>
              <given-names>ZM</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ishiko</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakada</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Utsugisawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kharbanda</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regulation of Rad51 function by c-Abl in response to DNA damage</article-title>
          <source>J Biol Chem</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>3799</fpage>
          <lpage>3802</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.273.7.3799</pub-id>
          <pub-id pub-id-type="pmid">9461559</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR79">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PALB2 links BRCA1 and BRCA2 in the DNA-damage response</article-title>
          <source>Curr Biol</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>524</fpage>
          <lpage>529</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cub.2009.02.018</pub-id>
          <pub-id pub-id-type="pmid">19268590</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR80">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Willers</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>DT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair</article-title>
          <source>Mol Cell Biol</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>708</fpage>
          <lpage>718</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.24.2.708-718.2004</pub-id>
          <pub-id pub-id-type="pmid">14701743</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR81">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mullen</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Elkon</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of primary transcriptional regulation of cell cycle-regulated genes upon DNA damage</article-title>
          <source>Cell Cycle</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>972</fpage>
          <lpage>981</lpage>
          <pub-id pub-id-type="doi">10.4161/cc.6.8.4106</pub-id>
          <pub-id pub-id-type="pmid">17404513</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
